{
  "tree": {
    "version": "2.0",
    "id": "120904",
    "metadata": {
      "template": "false",
      "default": "false",
      "schemaVersion": "0.2",
      "lastModifiedDate": "2019-08-22T12:29:48.95-04:00",
      "latestVersion": "0.0.3",
      "type": "decision-tree",
      "title": "Acute decompensated heart failure: Determining if a hospitalized adult is ready for discharge"
    },
    "defaultPermission": "Read",
    "dependencies": {},
    "rootNode": "5cacf86f21c1f40010d2fdc1"
  },
  "nodes": [
    {
      "id": "5cacf86f21c1f40010d2fdd6",
      "metadata": {
        "resourceId": "\"5c79300b8050090cc5ac8e48\"",
        "title": "\"Required Tests\"",
        "content": "\"<p>Serial serum creatinine values (to determine the trend in kidney function) and serial serum electrolytes (ie, potassium, magnesium) are required to answer the questions that will follow.</p>\\n\"",
        "resourceType": "\"infoPopup\""
      },
      "tags": [
        "infoPopup",
        "resource"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e1f",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3897bc24076a92270e1e"
      ]
    },
    {
      "id": "5cbf389abc24076a92270e54",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf389abc24076a92270e53"
      ]
    },
    {
      "id": "5cdab7577920bd0015e7324f",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab7577920bd0015e7324e"
      ]
    },
    {
      "id": "5cbf389bbc24076a92270e65",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Some patients with HFrEF who are treated with both a beta blocker and an ARNI, ACE inhibitor, or ARB should also receive an MRA to improve morbidity and mortality. Specifically:</p>\\n\\n<ul>\\n   <li>Patients with ejection fraction &lt;35% who have <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf897afb724bd988d1186b\\\">NYHA functional class</span> II, III, or IV heart failure.</li>\\n   <li>Patients with ejection fraction &le;40% who have had an ST-elevation MI and who also have either NYHA class II, III, or IV heart failure or diabetes mellitus.</li>\\n</ul>\\n\\n<p>In these patients who are admitted for acute heart failure, an MRA should generally be initiated unless one or more of the following apply:</p>\\n\\n<ul>\\n   <li>The patient underwent temporary discontinuation or dose reduction, during the hospitalization, of their ARNI, ACE inhibitor, or ARB.</li>\\n   <li>The patient underwent temporary discontinuation or dose reduction of their beta blocker.</li>\\n   <li>The patient has an estimated glomerular filtration rate (eGFR) &le;30 mL/min/1.73 m<sup>2</sup>.</li>\\n   <li>The patient has a serum potassium &ge;5.0 mEq/L.</li>\\n   <li>The patient has a known intolerance to MRAs.</li>\\n</ul>\\n\"",
        "resourceIds": "[\"5caf897afb724bd988d1186b\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf8806305efe0016a09a72",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking a beta blocker for less than 24 hours should be monitored for adverse effects, including hypoperfusion and bradycardia, before discharge from the hospital is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5ce6b390409cdb9b34732b8b",
      "metadata": {
        "resourceId": "\"5ce6b390409cdb9b34732b8c\"",
        "contentId": "52683",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"New York Heart Association (NYHA) functional class\"",
        "url": "\"https://qawww.utdlab.com/contents/image?imageKey=ID/52683&source=icg&topicId=120904\"",
        "resourceType": "\"utd-Graphic\""
      },
      "tags": [
        "resource",
        "utd-Graphic"
      ]
    },
    {
      "id": "5cbf3896bc24076a92270e11",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous inotropes or intravenous vasodilators to manage their heart failure within the last 24 hours are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf4fde07881d001522ac92",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaa83d57b1db001544d8b2",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaa83d57b1db001544d8b1"
      ]
    },
    {
      "id": "5cdab6fb7920bd0015e7324c",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Some patients with HFrEF who are treated with both a beta blocker and an ARNI, ACE inhibitor, or ARB should also receive an MRA to improve morbidity and mortality. Specifically:</p>\\n\\n<ul>\\n   <li>Patients with ejection fraction &lt;35% who have <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf897afb724bd988d1186b\\\">NYHA functional class</span> II, III, or IV heart failure.</li>\\n   <li>Patients with ejection fraction &le;40% who have had an ST-elevation MI and who also have either NYHA class II, III, or IV heart failure or diabetes mellitus.</li>\\n</ul>\\n\\n<p>In these patients who are admitted for acute heart failure, an MRA should generally be initiated unless one or more of the following apply:</p>\\n\\n<ul>\\n   <li>The patient underwent temporary discontinuation or dose reduction, during the hospitalization, of their ARNI, ACE inhibitor, or ARB.</li>\\n   <li>The patient underwent temporary discontinuation or dose reduction of their beta blocker.</li>\\n   <li>The patient has an eGFR &le;30 mL/min/1.73 m<sup>2</sup>.</li>\\n   <li>The patient has a serum potassium &ge;5.0 mEq/L.</li>\\n   <li>The patient has a known intolerance to MRAs.</li>\\n</ul>\\n\\n<p>Should the patient be initiated on an MRA: $(MRA_indicated_1).</p>\\n\"",
        "resourceIds": "[\"5caf897afb724bd988d1186b\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdd9dc664dab00011f81e7f",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdd9dc664dab00011f81e7e"
      ]
    },
    {
      "id": "5cdaac1357b1db001544d8c0",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaac1357b1db001544d8bf"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bf1",
      "metadata": {
        "layout": "{\"width\":null,\"height\":null,\"offsetNodeByY\":0,\"offsetNodeByX\":1}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37eb19dc0b497eb29c03"
      ]
    },
    {
      "id": "5d2c9fc9ab650a0a4300b3ab",
      "metadata": {
        "resourceId": "\"5d2c9fc9ab650a0a4300b3ac\"",
        "contentId": "52683",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"NYHA functional class\"",
        "url": "\"https://qawww.utdlab.com/contents/image?imageKey=ID/52683&source=icg&topicId=120904\"",
        "resourceType": "\"utd-Graphic\""
      },
      "tags": [
        "resource",
        "utd-Graphic"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e9b",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394dbc24076a92270e9a"
      ]
    },
    {
      "id": "5cbf849c2acfa8001101e3fc",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking an ARNI, ACE inhibitor, or ARB for less than 24 hours should be monitored for adverse effects, including hypotension, worsening kidney function, and a concerning rise in serum potassium, before discharge from the hospital is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e40",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3899bc24076a92270e3f"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdc9",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p><span class=\\\"tf-info-popup\\\" tf-resource-id=\\\"5c79300b8050090cc5ac8e48\\\">Required Tests</span>&nbsp; &nbsp; &nbsp;<span class=\\\"tf-info-popup\\\" tf-resource-id=\\\"5c7930208050090cc5ac8e4c\\\">Exclusions</span>&nbsp; &nbsp; &nbsp;<span class=\\\"tf-info-popup\\\" tf-resource-id=\\\"5c79305e8050090cc5ac8e50\\\">Disclaimer</span></p>\\n\"",
        "resourceIds": "[\"5c79300b8050090cc5ac8e48\",\"5c7930208050090cc5ac8e4c\",\"5c79305e8050090cc5ac8e50\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cb08c9eb9e5980010e9fcd3",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cb08c9eb9e5980010e9fcd2"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e23",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3897bc24076a92270e22"
      ]
    },
    {
      "id": "5cacfd2fd1653882bffcfd43",
      "metadata": {
        "layout": "{\"width\":140,\"height\":60,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "title": "\"Fill in Node Title\""
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cacfd30d1653882bffcfd4a"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c11",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate (or resume) therapy with a beta blocker</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ed19dc0b497eb29c21"
      ]
    },
    {
      "id": "5caf41ddc2b59b001152b6e3",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf41ddc2b59b001152b6e2"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdd1",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cacf86f21c1f40010d2fdd2"
      ]
    },
    {
      "id": "5caf9494fb724bd988d11889",
      "metadata": {
        "resourceId": "\"5caf9494fb724bd988d1188a\"",
        "headingReferenceId": "\"H775063374\"",
        "contentId": "7007",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"seasonal influenza\"",
        "url": "\"https://qawww.utdlab.com/contents/7007?source=icg&topicId=120904&anchor=H775063374#H775063374\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf394bbc24076a92270e77",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c0f",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Consult a heart failure specialist</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ed19dc0b497eb29c1e",
        "5cbf37ed19dc0b497eb29c1f"
      ]
    },
    {
      "id": "5cdabd6cec199540a8d2e028",
      "metadata": {
        "resourceId": "\"5cdabd6cec199540a8d2e029\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "115372",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Society guideline links: Heart failure in adults\"",
        "url": "\"https://qawww.utdlab.com/contents/115372?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-Society_Guidelines\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e89",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394cbc24076a92270e88"
      ]
    },
    {
      "id": "5cbf389bbc24076a92270e60",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3952bc24076a92270ed0",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3952bc24076a92270ecf"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270eb1",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf94b5c2b59b001152b920",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>The patient is</p>\\n\\n<p>suitable for discharge</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf94b6c2b59b001152b923",
        "5cb0a4c5f6e0b60013cc31b7"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e46",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3899bc24076a92270e45"
      ]
    },
    {
      "id": "5cbf3a01bc24076a92270f11",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a01bc24076a92270f10"
      ]
    },
    {
      "id": "5d2dce486219ae73dc8cd54b",
      "metadata": {
        "resourceId": "\"5d2dce486219ae73dc8cd54c\"",
        "contentId": "52683",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"NYHA functional class\"",
        "url": "\"https://qawww.utdlab.com/contents/image?imageKey=ID/52683&source=icg&topicId=120904\"",
        "resourceType": "\"utd-Graphic\""
      },
      "tags": [
        "resource",
        "utd-Graphic"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e25",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3897bc24076a92270e24"
      ]
    },
    {
      "id": "5caf4b6607881d001522ac85",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf4b6607881d001522ac84"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f1b",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Consult a heart</p>\\n\\n<p>failure specialist</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a03bc24076a92270f2a",
        "5cbf3a03bc24076a92270f2b"
      ]
    },
    {
      "id": "5caf91f7c2b59b001152b91c",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf91f7c2b59b001152b91f",
        "5cbf79d42acfa8001101e3f1"
      ]
    },
    {
      "id": "5d2e2b8fc95553ffb5bdad73",
      "metadata": {
        "resourceId": "\"5d2e2b8fc95553ffb5bdad74\"",
        "headingReferenceId": "\"H15\"",
        "contentId": "3464",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"UpToDate content\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=3464&Bookmark=H15\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cdab72657b1db001544d9bc",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Some patients with HFrEF who are treated with both a beta blocker and an ARNI, ACE inhibitor, or ARB should also receive an MRA to improve morbidity and mortality. Specifically:</p>\\n\\n<ul>\\n   <li>Patients with ejection fraction &lt;35% who have <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2dc980ce3b2f16b037a822\\\">NYHA functional class</span> II, III, or IV heart failure.</li>\\n   <li>Patients with ejection fraction &le;40% who have had an ST-elevation MI and who also have either NYHA class II, III, or IV heart failure or diabetes mellitus.</li>\\n</ul>\\n\\n<p>In these patients who are admitted for acute heart failure, an MRA should generally be initiated unless one or more of the following apply:</p>\\n\\n<ul>\\n   <li>The patient underwent temporary discontinuation or dose reduction, during the hospitalization, of their ARNI, ACE inhibitor, or ARB.</li>\\n   <li>The patient underwent temporary discontinuation or dose reduction of their beta blocker.</li>\\n   <li>The patient has an eGFR &le;30 mL/min/1.73 m<sup>2</sup>.</li>\\n   <li>The patient has a serum potassium &ge;5.0 mEq/L.</li>\\n   <li>The patient has a known intolerance to MRAs.</li>\\n</ul>\\n\\n<p>Should the patient be initiated on an MRA: $(MRA_indicated_2).</p>\\n\"",
        "resourceIds": "[\"5d2dc980ce3b2f16b037a822\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e2e",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate (or resume)</p>\\n\\n<p>therapy with an ARNI,</p>\\n\\n<p>ACE inhibitor, or ARB</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3899bc24076a92270e3e",
        "5cbf871e2acfa8001101e403"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdc7",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>The patient should not be discharged unless the precipitating condition has been suitably treated:</p>\\n\\n<ul>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cb087647002070be1d0017a\\\">Acute coronary syndrome</span> &ndash; Patients with ST-elevation myocardial infarction (MI) are typically treated with revascularization. Patients with non-ST-elevation MI or unstable angina should usually undergo early angiography with revascularization if appropriate.</li>\\n   <li>Acute or progressive valvular disease &ndash; Valvular heart disease is common in patients with heart failure and may precipitate acute heart failure. The management depends upon the type of valvular disease but may include surgical repair or transcatheter valve replacement (appropriate management should be planned or carried out prior to discharge).</li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cb089d57002070be1d0018e\\\">Atrial fibrillation</span> &ndash; Therapy of atrial fibrillation in patients with heart failure includes rate or rhythm control and, often, anticoagulation. Rhythm control is usually attempted as the initial strategy. If rhythm or rate control is difficult to attain, referral to an electrophysiology (EP) specialist is indicated. Guidance on anticoagulation in patients with atrial fibrillation is provided in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5ce69143c8bc68582218ebfe\\\">UpToDate Pathway</span>.</li>\\n   <li>Severe hypertension &ndash; Most patients who present with acute heart failure in the setting of <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cb0898b7002070be1d0018c\\\">severe hypertension</span> are older, have preserved ejection fraction (ie, HFpEF), and have a systolic pressure that is usually &gt;180 mmHg at the time of hospitalization. Diuretics and vasodilator therapy are typically used to treat such patients. The <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cb0892c7002070be1d00184\\\">immediate goal</span> is at least a 10 to 15% reduction in blood pressure; further reduction is warranted, although <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cb089527002070be1d0018a\\\">goal blood pressure</span> does not need to be achieved during hospitalization.</li>\\n   <li>Infection &ndash; Patients who have acute heart failure precipitated by infection should be receiving appropriate antimicrobial therapy and have signs of resolution of the infection before discharge.</li>\\n   <li>NSAIDs &ndash; Patients who developed acute heart failure after taking NSAIDs should discontinue these medications (alternative therapy for pain management can be initiated if necessary).</li>\\n</ul>\\n\"",
        "resourceIds": "[\"5cb087647002070be1d0017a\",\"5cb089d57002070be1d0018e\",\"5ce69143c8bc68582218ebfe\",\"5cb0898b7002070be1d0018c\",\"5cb0892c7002070be1d00184\",\"5cb089527002070be1d0018a\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf4f3707881d001522ac8b",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4f3707881d001522ac8a"
      ]
    },
    {
      "id": "5cbf37ef19dc0b497eb29c32",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ef19dc0b497eb29c31"
      ]
    },
    {
      "id": "5cbf39ffbc24076a92270ef2",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf864f2acfa8001101e3ff",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf864f2acfa8001101e3fe"
      ]
    },
    {
      "id": "5cacfd2fd1653882bffcfd41",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p><span class=\\\"tf-info-popup\\\" tf-resource-id=\\\"5c79300b8050090cc5ac8e48\\\">Required Tests</span>&nbsp; &nbsp; &nbsp;<span class=\\\"tf-info-popup\\\" tf-resource-id=\\\"5c7930208050090cc5ac8e4c\\\">Exclus<span class=\\\"tf-info-popup\\\" tf-resource-id=\\\"5cacfc88efc14b3e9e2e04f1\\\">Required tests</span>ions</span>&nbsp; &nbsp; &nbsp;<span class=\\\"tf-info-popup\\\" tf-resource-id=\\\"5c79305e8050090cc5ac8e50\\\">Disclaimer</span></p>\\n\"",
        "resourceIds": "[\"5c79300b8050090cc5ac8e48\",\"5c7930208050090cc5ac8e4c\",\"5cacfc88efc14b3e9e2e04f1\",\"5c79305e8050090cc5ac8e50\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5ced48a0f5bc96001112f307",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient received intravenous inotropes or vasodilators during the previous 24 hours: $(inotropes_yes_1).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf8b052acfa8001101e409",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf8b052acfa8001101e408"
      ]
    },
    {
      "id": "5cbf37ed19dc0b497eb29c1c",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c1b"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e82",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394cbc24076a92270e81"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270f01",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a00bc24076a92270f00"
      ]
    },
    {
      "id": "5cbf3951bc24076a92270ec9",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3951bc24076a92270ec8"
      ]
    },
    {
      "id": "5cbf7a4a623900e00c42e51f",
      "metadata": {
        "resourceId": "\"5cbf7a4a623900e00c42e51e\"",
        "title": "\"utd-abbreviation\"",
        "sectionType": "\"utd-abbreviation\"",
        "content": "\"<ul>\\n   <li>ACE: angiotensin-converting enzyme</li>\\n   <li>ARB: angiotensin receptor blocker</li>\\n   <li>ARNI: angiotensin receptor-neprilysin inhibitor</li>\\n   <li>CRT: cardiac resynchronization therapy</li>\\n   <li>eGFR: estimated glomerular filtration rate</li>\\n   <li>EP: electrophysiology</li>\\n   <li>HFpEF: heart failure with preserved ejection fraction</li>\\n   <li>HFrEF: heart failure with reduced ejection fraction</li>\\n   <li>ICD: implantable cardioverter-defibrillator</li>\\n   <li>IV: intravenous</li>\\n   <li>LBBB: left bundle branch block</li>\\n   <li>MI: myocardial infarction</li>\\n   <li>MRA: mineralocorticoid receptor antagonist</li>\\n   <li>NSAID: nonsteroidal antiinflammatory drug</li>\\n   <li>NYHA: New York Heart Association</li>\\n   <li>SCD: sudden cardiac death</li>\\n   <li>VT: ventricular tachycardia</li>\\n</ul>\\n\"",
        "resourceType": "\"section\"",
        "resourceIds": "[]"
      },
      "tags": [
        "resource",
        "section",
        "utd-abbreviation"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e9e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with a beta blocker to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should generally be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf3924c2b59b001152b6c8",
      "metadata": {
        "nodes": "[{\"id\":\"5caf3924c2b59b001152b6c9\",\"type\":\"start\",\"position\":{\"x\":80,\"y\":0}},{\"id\":\"5caf3924c2b59b001152b6ca\",\"type\":\"endpoint\",\"position\":{\"x\":80,\"y\":390},\"summarySkipped\":\"<p>Select &quot;Reset&quot;&nbsp;to indicate whether an EP consult will be ordered (outpatient appointment may be appropriate).</p>\\n\",\"decisionSummarySkipped\":\"<p>Approach selected: No orders were selected.</p>\\n\"},{\"id\":\"5caf392f7206495558326989\",\"title\":\"EP consult\",\"description\":\"<p><strong>Order an EP&nbsp;consult.</strong></p>\\n\",\"type\":\"radio\",\"variable\":\"order_EP_1\",\"options\":[{\"selectedValue\":\"Arrange an outpatient EP consult\",\"variable\":\"order_EP_1_opt1\",\"title\":\"<p>Arrange an outpatient EP consult</p>\\n\",\"includeInSummary\":true,\"orderSummary\":\"<p>$(order_EP_1)</p>\\n\",\"decisionSummary\":\"<p>Approach selected: $(order_EP_1).</p>\\n\",\"category\":\"others\"},{\"selectedValue\":\"Approach other than ordering an EP consult\",\"variable\":\"order_EP_1_opt2\",\"title\":\"<p>Approach other than ordering an EP consult</p>\\n\",\"includeInSummary\":true,\"orderSummary\":\"<p>$(order_EP_1)</p>\\n\",\"decisionSummary\":\"<p>Approach selected: $(order_EP_1).</p>\\n\",\"category\":\"others\"}],\"position\":{\"x\":80,\"y\":130},\"blockRender\":false,\"category\":\"others\",\"orderSummary\":\"<p>$(order_EP_1)</p>\\n\",\"decisionSummary\":\"<p>Approach selected: $(order_EP_1).</p>\\n\",\"includeInSummary\":true},{\"id\":\"5cf7d8a291a77566a32fabe1\",\"type\":\"function\",\"expression\":\"$(EP_consult_ordered) = 1\",\"position\":{\"x\":80,\"y\":260}}]",
        "title": "\"<p>EP consult</p>\\n\"",
        "connections": "[{\"source\":\"5caf3924c2b59b001152b6c9:out:0\",\"target\":\"5caf392f7206495558326989:in\",\"id\":\"5d2e14ae5fc9e5a77d774f3a\"},{\"source\":\"5caf392f7206495558326989:out:0\",\"target\":\"5cf7d8a291a77566a32fabe1:in\",\"id\":\"5d2e14ae5fc9e5a77d774f3b\"},{\"source\":\"5cf7d8a291a77566a32fabe1:out:0\",\"target\":\"5caf3924c2b59b001152b6ca:in\",\"id\":\"5d2e14ae5fc9e5a77d774f3c\"}]",
        "resourceIds": "[]",
        "embedProperties": "{\"isExtraCommentSelected\":false}"
      },
      "tags": [
        "orderSet"
      ]
    },
    {
      "id": "5cbf7e362acfa8001101e3f3",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf7e362acfa8001101e3f2"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270f05",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a00bc24076a92270f04"
      ]
    },
    {
      "id": "5cbf7f402acfa8001101e3f7",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf7f402acfa8001101e3f6"
      ]
    },
    {
      "id": "5cdd9da164dab00011f81e7c",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient's blood pressure tolerated the ARNI, ACE inhibitor, or ARB, and have arrangements been made to monitor as an outpatient for worsening kidney function or a concerning rise in serum potassium: $(BP_stable_ACE_2).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdab47f7920bd0015e73241",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab47f7920bd0015e73240"
      ]
    },
    {
      "id": "5cbf389abc24076a92270e5c",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf363107881d001522ac68",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "hideQuestionAnswersBlock": "true",
        "shortTitle": "\"\"",
        "title": "\"<p>EP consult suggested</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf363207881d001522ac6b",
        "5caf3924c2b59b001152b6cb",
        "5cf7ed96c94a2d2877b1d841"
      ]
    },
    {
      "id": "5cbf89e22acfa8001101e406",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking an ARNI, ACE inhibitor, or ARB for less than 24 hours should be monitored for adverse effects, including hypotension, worsening kidney function, and a concerning rise in serum potassium, before discharge from the hospital is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f19",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>In patients with HFrEF, beta blockers may cause hypoperfusion and bradycardia. If a beta blocker is newly initiated or resumed after discontinuation, the patient should be monitored for at least several hours for these potential complications.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf8a35305efe0016a09a7b",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf8a34305efe0016a09a7a"
      ]
    },
    {
      "id": "5cdd9f8364dab00011f81e85",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdd9f8364dab00011f81e84"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29be2",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient being treated with an ARNI, ACE inhibitor, or ARB?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37e919dc0b497eb29bea",
        "5cbf37e919dc0b497eb29bec",
        "5cbf37ea19dc0b497eb29bee"
      ]
    },
    {
      "id": "5cbf80d5305efe0016a09a5f",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf80d5305efe0016a09a5e"
      ]
    },
    {
      "id": "5cdabc92ec199540a8d2e017",
      "metadata": {
        "resourceId": "\"5cdabc92ec199540a8d2e018\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "15655",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Patient education: Heart failure (The Basics)\"",
        "url": "\"https://qawww.utdlab.com/contents/15655?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-PAT\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bd2",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37e719dc0b497eb29bd1"
      ]
    },
    {
      "id": "5cbf7f302acfa8001101e3f5",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf7f302acfa8001101e3f4"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f14",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a01bc24076a92270f13"
      ]
    },
    {
      "id": "5d2dce3c6219ae73dc8cd549",
      "metadata": {
        "resourceId": "\"5d2dce3c6219ae73dc8cd54a\"",
        "contentId": "52683",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"New York Heart Association (NYHA) functional class\"",
        "url": "\"https://qawww.utdlab.com/contents/image?imageKey=ID/52683&source=icg&topicId=120904\"",
        "resourceType": "\"utd-Graphic\""
      },
      "tags": [
        "resource",
        "utd-Graphic"
      ]
    },
    {
      "id": "5ce6b475409cdb9b34732bb6",
      "metadata": {
        "resourceId": "\"5ce6b475409cdb9b34732bb7\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3475",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"CRT\"",
        "url": "\"https://qawww.utdlab.com/contents/3475?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5caf91f007881d001522af3e",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient already received these vaccinations, if appropriate?</strong></p>\\n\"",
        "variable": "\"vaccinated\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Has the patient already</p>\\n\\n<p>received pneumococcal and</p>\\n\\n<p>influenza vaccinations,</p>\\n\\n<p>if appropriate?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf91f007881d001522af41",
        "5caf94b5c2b59b001152b921",
        "5caf94be07881d001522af43",
        "5cdab80a7920bd0015e73251"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdca",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cacf86f21c1f40010d2fdcb"
      ]
    },
    {
      "id": "5caf3fa2c2b59b001152b6d1",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf3fa2c2b59b001152b6d0"
      ]
    },
    {
      "id": "5cacfab8a23d7e0015f1ad38",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>This UpToDate Pathway <strong>is not</strong> appropriate for patients with any of the following exclusions:</p>\\n\\n<ul>\\n   <li>Age &lt;18 years</li>\\n   <li>Pregnant</li>\\n   <li>Patient with a mechanical circulatory assist device</li>\\n   <li>Patient with a cardiac transplantation</li>\\n   <li>Patient receiving continuous or intermittent renal replacement therapy</li>\\n</ul>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3950bc24076a92270ebd",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4894c2b59b001152b6f0"
      ]
    },
    {
      "id": "5cad0bc4aa11590010e31631",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Consultation with an EP specialist to consider indications for an <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2dce066219ae73dc8cd542\\\">ICD</span> or for <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2dce2c6219ae73dc8cd548\\\">CRT</span> is suggested for:</p>\\n\\n<ul>\\n   <li>Patients with heart failure with reduced ejection fraction (HFrEF), an ejection fraction &le;35%, and <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2dce3c6219ae73dc8cd54a\\\">New York Heart Association (NYHA) functional class</span> II or III.</li>\\n   <li>Patients with HFrEF, a history of ischemic heart disease, an ejection fraction &le;35%, and NYHA class I, II, or III.</li>\\n   <li>Patients with HFrEF, an ejection fraction &le;35%, a QRS duration &ge;120 milliseconds, and NYHA class IV.</li>\\n   <li>Patients who have survived an episode of sudden cardiac death (SCD; prior to or during this hospitalization).</li>\\n   <li>Patients with a history of sustained ventricular tachycardia (VT).</li>\\n   <li>Patients with an ischemic heart disease and unexplained syncope.</li>\\n   <li>Patients with NYHA class III or IV who have a QRS duration &ge;150 milliseconds and left bundle branch block (LBBB).</li>\\n   <li>Patients with atrial fibrillation in whom rhythm and/or rate control has proven difficult to attain.</li>\\n</ul>\\n\"",
        "resourceIds": "[\"5d2dce066219ae73dc8cd542\",\"5d2dce2c6219ae73dc8cd548\",\"5d2dce3c6219ae73dc8cd54a\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5d2dce066219ae73dc8cd541",
      "metadata": {
        "resourceId": "\"5d2dce066219ae73dc8cd542\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "921",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"ICD\"",
        "url": "\"https://qawww.utdlab.com/contents/921?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5caf3fa2c2b59b001152b6d2",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaa55f57b1db001544d8af",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Factors that commonly precipitate acute heart failure, and that should be addressed during hospitalization, include:</p>\\n\\n<ul>\\n   <li>Acute coronary syndrome</li>\\n   <li>Acute or progressive valvular disease</li>\\n   <li>Atrial fibrillation</li>\\n   <li>Severe or worsened hypertension (a common precipitating factor in patients who have HFpEF)</li>\\n   <li>Infection</li>\\n   <li>Use of NSAIDs</li>\\n</ul>\\n\\n<p>Did the patient have one or more of these precipitating factors leading to hospitalization for acute heart failure: $(acute_disorder).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e7b",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Does the patient have HFrEF?</strong></p>\\n\"",
        "variable": "\"HFrEF_present_2\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Does the patient</p>\\n\\n<p>have HFrEF?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394cbc24076a92270e82",
        "5cbf394cbc24076a92270e83",
        "5cdaab9657b1db001544d8be"
      ]
    },
    {
      "id": "5cbf82782acfa8001101e3fa",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>A beta blocker should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of beta blockers in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacfd30d1653882bffcfd4a",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cacfd2fd1653882bffcfd49"
      ]
    },
    {
      "id": "5cdab914ec199540a8d2dff7",
      "metadata": {
        "resourceId": "\"5cdab914ec199540a8d2dff6\"",
        "title": "\"utd-professional-topic-section\"",
        "sectionType": "\"utd-professional-topic-section\"",
        "content": "\"<ul>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabb22ec199540a8d2dffb\\\">Approach to acute decompensated heart failure in adults</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabb30ec199540a8d2dffd\\\">Cardiac resynchronization therapy in heart failure: Indications</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabb3eec199540a8d2dfff\\\">Implantable cardioverter-defibrillators: Overview of indications, components, and functions</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabb51ec199540a8d2e001\\\">Overview of the therapy of heart failure with reduced ejection fraction</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabb66ec199540a8d2e003\\\">Pharmacologic therapy of heart failure with reduced ejection fraction</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabb77ec199540a8d2e005\\\">Primary prevention of sudden cardiac death in heart failure and cardiomyopathy</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabb83ec199540a8d2e007\\\">The management of atrial fibrillation in patients with heart failure</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabb92ec199540a8d2e009\\\">Treatment of acute decompensated heart failure: Components of therapy</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabb9fec199540a8d2e00b\\\">Treatment of acute decompensated heart failure: General considerations</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabbadec199540a8d2e00d\\\">Treatment of acute decompensated heart failure in acute coronary syndromes</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabbbcec199540a8d2e00f\\\">Treatment and prognosis of heart failure with preserved ejection fraction</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabbcbec199540a8d2e011\\\">Use of diuretics in patients with heart failure</span></li>\\n</ul>\\n\"",
        "resourceIds": "[\"5cdabb22ec199540a8d2dffb\",\"5cdabb30ec199540a8d2dffd\",\"5cdabb3eec199540a8d2dfff\",\"5cdabb51ec199540a8d2e001\",\"5cdabb66ec199540a8d2e003\",\"5cdabb77ec199540a8d2e005\",\"5cdabb83ec199540a8d2e007\",\"5cdabb92ec199540a8d2e009\",\"5cdabb9fec199540a8d2e00b\",\"5cdabbadec199540a8d2e00d\",\"5cdabbbcec199540a8d2e00f\",\"5cdabbcbec199540a8d2e011\"]",
        "resourceType": "\"section\""
      },
      "tags": [
        "utd-professional-topic-section",
        "resource",
        "section"
      ]
    },
    {
      "id": "5cbf8887305efe0016a09a74",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An MRA should be initiated. Guidance on initiation and titration of these agents in patients with HFrEF can be found in related <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2e0f7cf9e096b4271168e6\\\">UpToDate content</span>.</p>\\n\\n<p>After initiating an MRA, a discharged patient should be monitored carefully for the development of worsening kidney function or hyperkalemia.</p>\\n\"",
        "resourceIds": "[\"5d2e0f7cf9e096b4271168e6\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3898bc24076a92270e35",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3898bc24076a92270e34"
      ]
    },
    {
      "id": "5caf84af07881d001522ae0c",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate (or resume)</p>\\n\\n<p>therapy with a</p>\\n\\n<p>beta blocker</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf84af07881d001522ae0f",
        "5cbf82782acfa8001101e3fb"
      ]
    },
    {
      "id": "5cbf37ee19dc0b497eb29c2a",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c19",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>This patient is taking an ARNI, ACE inhibitor, or ARB and is also taking a beta blocker. Have these drugs been continued, without interruption or dose reduction, since prior to hospitalization?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e9c",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is a beta blocker not being used because the patient has active bronchospasm, because the patient has a hypersensitivity to beta blockers, or because, after it was introduced, it produced hypoperfusion or bradycardia?</strong></p>\\n\"",
        "variable": "\"no_BB_reason_2\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Beta blocker not</p>\\n\\n<p>being used because</p>\\n\\n<p>of intolerance?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394fbc24076a92270eae",
        "5cbf394fbc24076a92270eb0",
        "5cdab3787920bd0015e731e1"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270efb",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a00bc24076a92270efa"
      ]
    },
    {
      "id": "5cdaaa7557b1db001544d8ba",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaaa7557b1db001544d8b9"
      ]
    },
    {
      "id": "5caf4430c2b59b001152b6ea",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>&nbsp;</p>\\n\\n<ul>\\n</ul>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bfd",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"<p>Choose an option:</p>\\n\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Beta blocker not being used because of intolerance?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c10",
        "5cbf37ec19dc0b497eb29c12",
        "5cbf37ec19dc0b497eb29c14"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e2a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>In patients with HFrEF, ARNIs, ACE inhibitors, and ARBs may produce hypotension, impaired kidney function, and/or hyperkalemia. If one of these agents is newly initiated or resumed after discontinuation, the patient should be monitored at least several hours for the development of hypotension and should have outpatient follow-up of electrolytes and kidney function within one to two weeks.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf39ffbc24076a92270ef1",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5caf36a307881d001522ac73",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf36a307881d001522ac72"
      ]
    },
    {
      "id": "5cdd9a0e64dab00011f81e7b",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdd9a0d64dab00011f81e7a"
      ]
    },
    {
      "id": "5cbf394bbc24076a92270e76",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394bbc24076a92270e75"
      ]
    },
    {
      "id": "5cbf37ef19dc0b497eb29c31",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An MRA should be initiated. Guidance on initiation and titration of these agents in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf8cbafb724bd988d1187d\\\">topics</span>.</p>\\n\\n<p>After initiating an MRA, a dicharged patient should be monitored carefully for the development of worsening kidney function or hyperkalemia.</p>\\n\"",
        "resourceIds": "[\"5caf8cbafb724bd988d1187d\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdabbcbec199540a8d2e010",
      "metadata": {
        "resourceId": "\"5cdabbcbec199540a8d2e011\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3512",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Use of diuretics in patients with heart failure\"",
        "url": "\"https://qawww.utdlab.com/contents/3512?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cdabbadec199540a8d2e00c",
      "metadata": {
        "resourceId": "\"5cdabbadec199540a8d2e00d\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3498",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Treatment of acute decompensated heart failure in acute coronary syndromes\"",
        "url": "\"https://qawww.utdlab.com/contents/3498?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5ce822ad38e9311ed81f1c54",
      "metadata": {
        "resourceId": "\"5ce822ad38e9311ed81f1c55\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "15655",
        "isOriginalDescription": "true",
        "active": "true",
        "text": "\"Patient education: Heart failure (The Basics)\"",
        "url": "\"https://qawww.utdlab.com/contents/15655?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-PAT\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5caf33db4ac0c658ab9bf266",
      "metadata": {
        "resourceId": "\"5caf33db4ac0c658ab9bf267\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3475",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"cardiac resynchronization therapy\"",
        "url": "\"https://qawww.utdlab.com/contents/3475?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cacfd2fd1653882bffcfd42",
      "metadata": {
        "isSummaryLink": "false",
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cacfd2fd1653882bffcfd41"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e47",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate (or resume)</p>\\n\\n<p>therapy with a</p>\\n\\n<p>beta blocker</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf389abc24076a92270e57",
        "5cbf87bb305efe0016a09a71"
      ]
    },
    {
      "id": "5cdaaaaa7920bd0015e73122",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient been treated with oral diuretics (without any intravenous diuretic therapy) for at least 24 hours, and is the volume status stable or improving: $(volume_stable_better_24_2).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdc2",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cacf86f21c1f40010d2fdc3"
      ]
    },
    {
      "id": "5caf8c05c2b59b001152b91b",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf8c05c2b59b001152b91a"
      ]
    },
    {
      "id": "5caf87ac07881d001522af2c",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdd2",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaaacc57b1db001544d8bc",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaaacc57b1db001544d8bb"
      ]
    },
    {
      "id": "5caf363e07881d001522ac6c",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient received intravenous inotropes or vasodilators during the previous 24 hours?</strong></p>\\n\"",
        "variable": "\"inotropes_yes_3\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Received IV</p>\\n\\n<p>inotropes or vasodilators</p>\\n\\n<p>in the previous 24 hours?\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf3ded07881d001522ac79",
        "5caf3df4c2b59b001152b6cd",
        "5ced48ebf5bc96001112f30c"
      ]
    },
    {
      "id": "5cbf3bbfbc24076a92270f5d",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bd3",
      "metadata": {
        "isSummaryLink": "false",
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf3924c2b59b001152b6c8"
      ]
    },
    {
      "id": "5cbf389bbc24076a92270e67",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An MRA should be initiated. Guidance on initiation and titration of these agents in patients with HFrEF can be found in related <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2e0f65f9e096b4271168e4\\\">UpToDate content</span>.</p>\\n\\n<p>After initiating an MRA, a discharged patient should be monitored carefully for the development of worsening kidney function or hyperkalemia.</p>\\n\"",
        "resourceIds": "[\"5d2e0f65f9e096b4271168e4\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf4b6607881d001522ac87",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4b6607881d001522ac86"
      ]
    },
    {
      "id": "5cdab6007920bd0015e73247",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab6007920bd0015e73246"
      ]
    },
    {
      "id": "5cad0c09a23d7e0015f1ad43",
      "metadata": {
        "isSummaryLink": "false",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cad0c09a23d7e0015f1ad40"
      ]
    },
    {
      "id": "5cdaaacc57b1db001544d8bb",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient been treated with oral diuretics (without any intravenous diuretic therapy) for at least 24 hours, and is the volume status stable or improving: $(volume_stable_better_24_3).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e91",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394dbc24076a92270e90"
      ]
    },
    {
      "id": "5cbf8678305efe0016a09a6d",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf8678305efe0016a09a6c"
      ]
    },
    {
      "id": "5caf91f007881d001522af41",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf91f007881d001522af40"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f16",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a02bc24076a92270f15"
      ]
    },
    {
      "id": "5caf841bc2b59b001152b849",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking a beta blocker for only a few hours should be monitored for hypotension and bradycardia before discharge is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a04bc24076a92270f3e",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a04bc24076a92270f3d"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f27",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking a beta blocker for only a few hours should be monitored for hypotension and bradycardia before discharge is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e8d",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf394cbc24076a92270e8c"
      ]
    },
    {
      "id": "5cbf389bbc24076a92270e64",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5caf41d7c2b59b001152b6dc",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "true",
        "questionForChildren": "\"<p><strong>Is the patient being treated with one of these medications?</strong></p>\\n\"",
        "variable": "\"taking_RAS_3\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient being</p>\\n\\n<p>treated with an ARNI,</p>\\n\\n<p>ACE inhibitor, or ARB?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf41d7c2b59b001152b6df",
        "5caf4429c2b59b001152b6e5",
        "5caf4430c2b59b001152b6e9",
        "5cdaacd97920bd0015e7312f"
      ]
    },
    {
      "id": "5cbf3a01bc24076a92270f0e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking an ARNI, ACE inhibitor, or ARB for only a few hours should be monitored for hypotension before discharge is considered. Arrangements also need to be made to monitor for worsening kidney function or a concerning rise in serum potassium after the patient is discharged from the hospital.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394bbc24076a92270e73",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394cbc24076a92270e7a",
        "5cbf7e362acfa8001101e3f3"
      ]
    },
    {
      "id": "5cacfd30d1653882bffcfd4b",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29bda",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous inotropes or intravenous vasodilatores to manage their heart failure are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdab5d857b1db001544d9bb",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab5d857b1db001544d9ba"
      ]
    },
    {
      "id": "5cbf37ed19dc0b497eb29c24",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Should an MRA be initiated?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ee19dc0b497eb29c2d",
        "5cbf37ee19dc0b497eb29c2e",
        "5cbf37ef19dc0b497eb29c30"
      ]
    },
    {
      "id": "5cdabb22ec199540a8d2dffa",
      "metadata": {
        "resourceId": "\"5cdabb22ec199540a8d2dffb\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3497",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Approach to acute decompensated heart failure in adults\"",
        "url": "\"https://qawww.utdlab.com/contents/3497?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e49",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270eff",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a00bc24076a92270efe"
      ]
    },
    {
      "id": "5cbf3a01bc24076a92270f13",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An ARNI, ACE inhibitor, or ARB should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of these drugs in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5ce838afe0b85d7d8f548e6e\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5ce838afe0b85d7d8f548e6e\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf84af07881d001522ae0f",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf84af07881d001522ae0e"
      ]
    },
    {
      "id": "5cdaab267920bd0015e73125",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaab267920bd0015e73124"
      ]
    },
    {
      "id": "5cdab27757b1db001544d8cd",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Is a beta blocker not being used because the patient has active bronchospasm, because the patient has a hypersensitivity to beta blockers, or because, after it was introduced, it produced hypoperfusion or bradycardia: $(no_BB_reason).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37eb19dc0b497eb29c03",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37eb19dc0b497eb29c02"
      ]
    },
    {
      "id": "5caf3680c2b59b001152b6c5",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf3680c2b59b001152b6c4"
      ]
    },
    {
      "id": "5cdabb92ec199540a8d2e008",
      "metadata": {
        "resourceId": "\"5cdabb92ec199540a8d2e009\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3450",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Treatment of acute decompensated heart failure: Components of therapy\"",
        "url": "\"https://qawww.utdlab.com/contents/3450?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf3a01bc24076a92270f0f",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a01bc24076a92270f0e"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bff",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with a beta blocker to improve morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should generally be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.\\n\\n<p><strong>Is the patient being treated with a beta blocker?</strong></p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c12",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c11"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f1a",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a02bc24076a92270f19"
      ]
    },
    {
      "id": "5caf8b6c07881d001522af38",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Some patients with HFrEF who are treated with both a beta blocker and an ARNI, ACE inhibitor, or ARB should also receive an MRA to improve morbidity and mortality. Specifically:</p>\\n\\n<ul>\\n   <li>Patients with ejection fraction &lt;35% who have <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf897afb724bd988d1186b\\\">NYHA functional class</span> II, III, or IV heart failure.</li>\\n   <li>Patients with ejection fraction &le;40% who have had an ST-elevation myocardial infarction (MI) and who also have either NYHA class II, III, or IV heart failure or diabetes mellitus.</li>\\n</ul>\\n\\n<p>In these patients who are admitted for acute heart failure, an MRA should generally be initiated unless one or more of the following apply:</p>\\n\\n<ul>\\n   <li>The patient underwent temporary discontinuation or dose reduction, during the hospitalization, of their ARNI, ACE inhibitor, or ARB.</li>\\n   <li>The patient underwent temporary discontinuation or dose reduction of their beta blocker.</li>\\n   <li>The patient has an estimated glomerular filtration rate (eGFR) &le;30 mL/min/1.73 m<sup>2</sup>.</li>\\n   <li>The patient has a serum potassium &ge;5.0 mEq/L.</li>\\n   <li>The patient has a known intolerance to MRAs.</li>\\n</ul>\\n\"",
        "resourceIds": "[\"5caf897afb724bd988d1186b\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37e619dc0b497eb29bc3",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "title": "\"Fill in Node Title\""
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37e719dc0b497eb29bca"
      ]
    },
    {
      "id": "5cbf37ee19dc0b497eb29c27",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ed19dc0b497eb29c26"
      ]
    },
    {
      "id": "5cbf3a04bc24076a92270f39",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a04bc24076a92270f38"
      ]
    },
    {
      "id": "5d2e0dde61b5e742729b4ff5",
      "metadata": {
        "resourceId": "\"5d2e0dde61b5e742729b4ff6\"",
        "headingReferenceId": "\"H15\"",
        "contentId": "3464",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"UpToDate content\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=3464&Bookmark=H15\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bcf",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Some patients hospitalized for acute heart failure should be evaluated by an electrophysiology (EP) specialist. Such patients include those who have an indication for an implantable cardioverter-defibrillator (ICD) for <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf31d84ac0c658ab9bf261\\\">primary prevention</span> of sudden cardiac death (SCD), some who have <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf33114ac0c658ab9bf265\\\">survived an episode of cardiac arrest</span> or sustained ventricular tachycardia (VT), those who have an indication for <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf33db4ac0c658ab9bf267\\\">cardiac resynchronization therapy</span> (CRT), and those with <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf358b4ac0c658ab9bf269\\\">poorly controlled atrial fibrillation</span>:</p>\\n\\n<ul>\\n   <li>Patients with HFrEF, an ejection fraction &le;35%, and <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf31b54ac0c658ab9bf25f\\\">New York Heart Association (NYHA) functional class</span> II or III.</li>\\n   <li>Patients with a history of ischemic heart disease, HFrEF with ejection fraction &le;35%, and NYHA class I, II, or III.</li>\\n   <li>Patients with HFrEF, an ejection fraction &le;35%, a QRS duration &ge;120 milliseconds, and NYHA class IV.</li>\\n   <li>Patients who have survived an episode of SCD.</li>\\n   <li>Patient with a history of sustained VT.</li>\\n   <li>Patients with ischemic heart disease who have unexplained syncope.</li>\\n   <li>Patients with NYHA class III or IV who have a QRS duration &ge;150 milliseconds and left bundle branch block (LBBB).</li>\\n   <li>Patients with atrial fibrillation in whom rhythm and/or rate control has proven difficult to attain.</li>\\n</ul>\\n\\n<p><strong>Does the patient have any of the above reasons to undergo evaluation by an electrophysiologist?</strong></p>\\n\"",
        "resourceIds": "[\"5caf31d84ac0c658ab9bf261\",\"5caf33114ac0c658ab9bf265\",\"5caf33db4ac0c658ab9bf267\",\"5caf358b4ac0c658ab9bf269\",\"5caf31b54ac0c658ab9bf25f\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e06",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Consultation with an EP specialist to consider indications for an <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d02507acaa878f8603cb5a1\\\">ICD</span> or for <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d025097caa878f8603cb5a3\\\">CRT</span> is suggested for:</p>\\n\\n<ul>\\n   <li>Patients with heart failure with reduced ejection fraction (HFrEF), an ejection fraction &le;35%, and <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf31b54ac0c658ab9bf25f\\\">New York Heart Association (NYHA) functional class</span> II or III.</li>\\n   <li>Patients with HFrEF, a history of ischemic heart disease, an ejection fraction &le;35%, and NYHA class I, II, or III.</li>\\n   <li>Patients with HFrEF, an ejection fraction &le;35%, a QRS duration &ge;120 milliseconds, and NYHA class IV.</li>\\n   <li>Patients who have survived an episode of sudden cardiac death (SCD; prior to or during this hospitalization).</li>\\n   <li>Patients with a history of sustained ventricular tachycardia (VT).</li>\\n   <li>Patients with an ischemic heart disease and unexplained syncope.</li>\\n   <li>Patients with NYHA class III or IV who have a QRS duration &ge;150 milliseconds and left bundle branch block (LBBB).</li>\\n   <li>Patients with atrial fibrillation in whom rhythm and/or rate control has proven difficult to attain.</li>\\n</ul>\\n\"",
        "resourceIds": "[\"5d02507acaa878f8603cb5a1\",\"5d025097caa878f8603cb5a3\",\"5caf31b54ac0c658ab9bf25f\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaacb47920bd0015e7312d",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaacb47920bd0015e7312c"
      ]
    },
    {
      "id": "5cbf82782acfa8001101e3fb",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf82782acfa8001101e3fa"
      ]
    },
    {
      "id": "5cbf8a34305efe0016a09a7a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>A beta blocker should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of beta blockers in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cb0a248f6e0b60013cc31b4",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients should undergo a transthoracic echocardiogram prior to discharge if one or more of the following apply:</p>\\n\\n<ul>\\n   <li>The patient has not previously had an echocardiogram.</li>\\n   <li>The patient's acute decompensation was precipitated, at least in part, by an acute coronary syndrome.</li>\\n   <li>The reason for the patient's acute decompensation is unclear.</li>\\n</ul>\\n\\n<p>In such patients, echocardiographic findings may identify the type of heart failure, the presence of valvular disease, and/or other features that could require treatment before discharge.</p>\\n\\n<p>Is there a reason to obtain an echo prior to discharge: $(Reason_echo).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270eaf",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate (or resume)</p>\\n\\n<p>therapy with a</p>\\n\\n<p>beta blocker</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3950bc24076a92270ebf",
        "5cbf84f9305efe0016a09a67"
      ]
    },
    {
      "id": "5cbf37ee19dc0b497eb29c29",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ee19dc0b497eb29c28"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270efa",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with an angiotensin receptor-neprilysin inhibitor (ARNI), angiotensin-converting enzyme (ACE) inhibitor, or angiotensin receptor blocker (ARB) to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ef19dc0b497eb29c30",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ee19dc0b497eb29c2f"
      ]
    },
    {
      "id": "5cbf37e919dc0b497eb29be9",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Has the patient tolerated the ARNI, ACE inhibitor, or ARB for at least 24 hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ea19dc0b497eb29bf0",
        "5cbf37ea19dc0b497eb29bf2",
        "5cbf37ea19dc0b497eb29bf4"
      ]
    },
    {
      "id": "5cdaa55f57b1db001544d8b0",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaa55f57b1db001544d8af"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bf8",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ea19dc0b497eb29bf7"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e1e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous diuretics within the last 24 hours to manage their hypervolemia are at higher risk for recurrent acute heart failure as outpatients and therefore are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf389abc24076a92270e52",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3899bc24076a92270e51"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e22",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is an ARNI, ACE inhibitor, or ARB not being used for one or both of the following reasons?</strong></p>\\n\\n<ul>\\n   <li>The patient developed an adverse effect from the drug (ie, hypotension, worsening kidney function, or hyperkalemia).</li>\\n   <li>The patient has a history of angioedema or hypersensitivity to ARNIs or ACE inhibitors and has an allergy to single-agent ARBs.</li>\\n</ul>\\n\"",
        "variable": "\"no_ARNI_reason_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>ARNI, ACE inhibitor,</p>\\n\\n<p>or ARB not being used</p>\\n\\n<p>due to intolerance?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3897bc24076a92270e2d",
        "5cbf3897bc24076a92270e2f",
        "5cdaae8a7920bd0015e73131"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c13",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Is a beta blocker not being used because the patient has a hypersensitivity to beta blockers or because, after it was introduced, it produced hypoperfusion or bradycardia?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a03bc24076a92270f34",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3898bc24076a92270e3c",
      "metadata": {
        "isSummaryLink": "false",
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4894c2b59b001152b6f0"
      ]
    },
    {
      "id": "5cbf83ab305efe0016a09a63",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf83ab305efe0016a09a62"
      ]
    },
    {
      "id": "5cbf3a04bc24076a92270f3d",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An MRA should be initiated. Guidance on initiation and titration of these agents in patients with HFrEF can be found in related <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2e0dde61b5e742729b4ff6\\\">UpToDate content</span>.</p>\\n\\n<p>After initiating an MRA, a discharged patient should be monitored carefully for the development of worsening kidney function or hyperkalemia.</p>\\n\"",
        "resourceIds": "[\"5d2e0dde61b5e742729b4ff6\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf389bbc24076a92270e68",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf389bbc24076a92270e67"
      ]
    },
    {
      "id": "5caf363e07881d001522ac6d",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf363e07881d001522ac6c"
      ]
    },
    {
      "id": "5cbf3896bc24076a92270e15",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3897bc24076a92270e1f",
        "5cbf8678305efe0016a09a6d"
      ]
    },
    {
      "id": "5cb09b0521c262c35a0e063d",
      "metadata": {
        "resourceId": "\"5cb09b0521c262c35a0e063e\"",
        "displayTag": "\"2\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "120452",
        "active": "true",
        "isOriginalDescription": "true",
        "text": "\"Heart failure: Selecting the site of care from the emergency department\"",
        "url": "\"https://qawww.utdlab.com/pathway/120452?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-Pathway\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5caf849a07881d001522ae08",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Consult a heart</p>\\n\\n<p>failure specialist</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf849a07881d001522ae0b",
        "5caf8543fb724bd988d1184b"
      ]
    },
    {
      "id": "5cdabbbcec199540a8d2e00e",
      "metadata": {
        "resourceId": "\"5cdabbbcec199540a8d2e00f\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3461",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Treatment and prognosis of heart failure with preserved ejection fraction\"",
        "url": "\"https://qawww.utdlab.com/contents/3461?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e92",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>In patients with HFrEF, ARNIs, ACE inhibitors, and ARBs may produce hypotension, impaired kidney function, and/or hyperkalemia. If one of these agents is newly initiated or resumed after discontinuation, the patient should be monitored at least several hours for the development of hypotension and should have outpatient follow-up of electrolytes and kidney function within one to two weeks.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cad0baeaa11590010e3162d",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>The patient either has unclassified heart failure or has clinical features that suggest a significant change in cardiac function may have occurred. Consequently, an echocardiogram should be obtained.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a04bc24076a92270f35",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a03bc24076a92270f34"
      ]
    },
    {
      "id": "5caf87b207881d001522af31",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf87b207881d001522af30"
      ]
    },
    {
      "id": "5cbf3898bc24076a92270e38",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking an ARNI, ACE inhibitor, or ARB for only a few hours should be monitored for hypotension before discharge is considered. Arrangements also need to be made to monitor for worsening kidney function or a concerning rise in serum potassium after the patient is discharged from the hospital.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c1a",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c19"
      ]
    },
    {
      "id": "5caf36aa07881d001522ac76",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf39febc24076a92270ee1",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf39ffbc24076a92270ee8",
        "5cbf88e62acfa8001101e405"
      ]
    },
    {
      "id": "5cdabcc2ec199540a8d2e01d",
      "metadata": {
        "resourceId": "\"5cdabcc2ec199540a8d2e01e\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "86003",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Patient education: Heart failure with preserved ejection fraction (The Basics)\"",
        "url": "\"https://qawww.utdlab.com/contents/86003?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-PAT\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf81f62acfa8001101e3f9",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf81f62acfa8001101e3f8"
      ]
    },
    {
      "id": "5cbf3c1cbc24076a92270f6e",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cbf389abc24076a92270e57",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf389abc24076a92270e56"
      ]
    },
    {
      "id": "5ce459c4a5a9440015d9da5d",
      "metadata": {
        "isSummaryLink": "false",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5ce459c4a5a9440015d9da5c"
      ]
    },
    {
      "id": "5cbf79d42acfa8001101e3f1",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf79d42acfa8001101e3f0"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e7f",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaabb87920bd0015e73129",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaabb87920bd0015e73128"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270eb0",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394fbc24076a92270eaf"
      ]
    },
    {
      "id": "5cbf39ffbc24076a92270eef",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "true",
        "questionForChildren": "\"<p><strong>Is the patient being treated with one of these medications?</strong></p>\\n\"",
        "variable": "\"taking_RAS\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient being</p>\\n\\n<p>treated with an ARNI,</p>\\n\\n<p>ACE inhibitor, or ARB?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a00bc24076a92270ef7",
        "5cbf3a00bc24076a92270ef9",
        "5cbf3a00bc24076a92270efb",
        "5cdaac1357b1db001544d8c0"
      ]
    },
    {
      "id": "5cbf3894bc24076a92270df9",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient already been evaluated by an EP specialist for ICD or CRT?</strong></p>\\n\"",
        "variable": "\"EP_consult_already\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Has the patient had</p>\\n\\n<p>an EP consult?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "subtreeRoot",
        "node"
      ],
      "children": [
        "5cbf39febc24076a92270edf",
        "5cbf3894bc24076a92270dfd",
        "5cdaa83d57b1db001544d8b2",
        "5ce457b42f86000015eaf1d2"
      ]
    },
    {
      "id": "5ce822e238e9311ed81f1c5b",
      "metadata": {
        "resourceId": "\"5ce822e238e9311ed81f1c5c\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "16443",
        "isOriginalDescription": "true",
        "active": "true",
        "text": "\"Patient education: Heart failure and atrial fibrillation (The Basics)\"",
        "url": "\"https://qawww.utdlab.com/contents/16443?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-PAT\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e83",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cdabbe9ec199540a8d2e015",
      "metadata": {
        "resourceId": "\"5cdabbe9ec199540a8d2e014\"",
        "sectionType": "\"utd-patient-education-section\"",
        "title": "\"utd-patient-education-section\"",
        "content": "\"<ul>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5ce822ad38e9311ed81f1c55\\\">Patient education: Heart failure (The Basics)</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5ce822d038e9311ed81f1c5a\\\">Patient education: Heart failure (Beyond the Basics)</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5ce822e238e9311ed81f1c5c\\\">Patient education: Heart failure and atrial fibrillation (The Basics)</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5ce822f438e9311ed81f1c5e\\\">Patient education: Heart failure with preserved ejection fraction (The Basics)</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5ce8230a38e9311ed81f1c60\\\">Patient education: Heart failure with reduced ejection fraction (The Basics)</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5ce8232038e9311ed81f1c62\\\">Patient education: Medicines for heart failure with reduced ejection fraction (The Basics)</span></li>\\n</ul>\\n\"",
        "resourceType": "\"section\"",
        "resourceIds": "[\"5ce822ad38e9311ed81f1c55\",\"5ce822d038e9311ed81f1c5a\",\"5ce822e238e9311ed81f1c5c\",\"5ce822f438e9311ed81f1c5e\",\"5ce8230a38e9311ed81f1c60\",\"5ce8232038e9311ed81f1c62\"]"
      },
      "tags": [
        "resource",
        "section",
        "utd-patient-education-section"
      ]
    },
    {
      "id": "5cf7d4ceb8e74100125bf539",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e97",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394dbc24076a92270e96"
      ]
    },
    {
      "id": "5cdabca2ec199540a8d2e019",
      "metadata": {
        "resourceId": "\"5cdabca2ec199540a8d2e01a\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3446",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Patient education: Heart failure (Beyond the Basics)\"",
        "url": "\"https://qawww.utdlab.com/contents/3446?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-PAT\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf37eb19dc0b497eb29c04",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF who are hospitalized for acute heart failure and who are unable to tolerate treatment with an ARNI, ACE inhibitor, or ARB should be evaluated by a heart failure specialist to help navigate other treatment options.\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5d2e0f7cf9e096b4271168e5",
      "metadata": {
        "resourceId": "\"5d2e0f7cf9e096b4271168e6\"",
        "headingReferenceId": "\"H15\"",
        "contentId": "3464",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"UpToDate content\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=3464&Bookmark=H15\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdc3",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Factors that commonly precipitate acute heart failure, and that should be addressed during hospitalization, include:</p>\\n\\n<ul>\\n   <li>Acute coronary syndrome</li>\\n   <li>Acute or progressive valvular disease</li>\\n   <li>Atrial fibrillation</li>\\n   <li>Severe or worsened hypertension (a common precipitating factor in patients who have heart failure with preserved ejection fraction [HFpEF])</li>\\n   <li>Infection</li>\\n   <li>Use of nonsteroidal antiinflammatory drugs (NSAIDs)</li>\\n</ul>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdc6",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cacf86f21c1f40010d2fdc7"
      ]
    },
    {
      "id": "5cbf394bbc24076a92270e74",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394bbc24076a92270e73"
      ]
    },
    {
      "id": "5cbf8523305efe0016a09a68",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking a beta blocker for less than 24 hours should be monitored for adverse effects, including hypoperfusion and bradycardia, before discharge from the hospital is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf389bbc24076a92270e5f",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf389abc24076a92270e5e"
      ]
    },
    {
      "id": "5ce8230a38e9311ed81f1c5f",
      "metadata": {
        "resourceId": "\"5ce8230a38e9311ed81f1c60\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "86147",
        "isOriginalDescription": "true",
        "active": "true",
        "text": "\"Patient education: Heart failure with reduced ejection fraction (The Basics)\"",
        "url": "\"https://qawww.utdlab.com/contents/86147?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-PAT\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5caf4429c2b59b001152b6e4",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient's blood pressure tolerated the ARNI, ACE inhibitor, or ARB, and have arrangements been made to monitor as an outpatient for worsening kidney function or a concerning rise in serum potassium?</strong></p>\\n\"",
        "variable": "\"BP_stable_ACE_3\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Stable blood pressure on ARNI, ACE inhibitor,</p>\\n\\n<p>and outpatient laboratory</p>\\n\\n<p>follow-up arranged?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf442ac2b59b001152b6e7",
        "5caf4f3d07881d001522ac8d",
        "5caf4b6607881d001522ac85",
        "5cdd9dc664dab00011f81e7f"
      ]
    },
    {
      "id": "5caf521207881d001522ac98",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is a beta blocker not being used because the patient has active bronchospasm, because the patient has a hypersensitivity to beta blockers, or because, after it was introduced, it produced hypoperfusion or bradycardia?</strong></p>\\n\"",
        "variable": "\"no_BB_reason_3\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Beta blocker not being used because of intolerance?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf849a07881d001522ae09",
        "5caf84af07881d001522ae0d",
        "5cdab3a357b1db001544d944"
      ]
    },
    {
      "id": "5cbf37ed19dc0b497eb29c25",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ed19dc0b497eb29c24"
      ]
    },
    {
      "id": "5caf442ac2b59b001152b6e7",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4429c2b59b001152b6e6"
      ]
    },
    {
      "id": "5caf95aefb724bd988d11893",
      "metadata": {
        "resourceId": "\"5caf95aefb724bd988d11894\"",
        "headingReferenceId": "\"H775063374\"",
        "contentId": "7007",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"topics\"",
        "url": "\"https://qawww.utdlab.com/contents/7007?source=icg&topicId=120904&anchor=H775063374#H775063374\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cad0baeaa11590010e3162c",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cad0baeaa11590010e3162b"
      ]
    },
    {
      "id": "5caf4fde07881d001522ac93",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4fde07881d001522ac92"
      ]
    },
    {
      "id": "5caf4430c2b59b001152b6e8",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is an ARNI, ACE inhibitor, or ARB not being used for one or both of the following reasons?</strong></p>\\n\\n<ul>\\n   <li>The patient developed an adverse effect from the drug (ie, hypotension, worsening kidney function, or hyperkalemia).</li>\\n   <li>The patient has a history of angioedema or hypersensitivity to ARNIs or ACE inhibitors and has an allergy to single-agent ARBs.</li>\\n</ul>\\n\"",
        "variable": "\"no_ARNI_reason_3\"",
        "shortTitle": "\"\"",
        "title": "\"<p>ARNI, ACE inhibitor,</p>\\n\\n<p>or ARB not being used</p>\\n\\n<p>due to intolerance?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf480e07881d001522ac7d",
        "5caf4815c2b59b001152b6ed",
        "5cdaaee157b1db001544d8c4"
      ]
    },
    {
      "id": "5cbf394ebc24076a92270ea3",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf394ebc24076a92270ea2"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bfa",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ea19dc0b497eb29bf9"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e04",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient received intravenous inotropes or vasodilators during the previous 24 hours?</strong></p>\\n\"",
        "variable": "\"inotropes_yes_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Received IV</p>\\n\\n<p>inotropes or vasodilators</p>\\n\\n<p>in the previous 24 hours?\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "subtreeRoot",
        "node"
      ],
      "children": [
        "5cbf3895bc24076a92270e0c",
        "5cbf3895bc24076a92270e0e",
        "5ced48a0f5bc96001112f308"
      ]
    },
    {
      "id": "5cbf39febc24076a92270ee3",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient been treated with oral diuretics (without any intravenous diuretic therapy) for at least 24 hours, and is the volume status stable or improving?</strong></p>\\n\"",
        "variable": "\"volume_stable_better_24\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Stable or improving</p>\\n\\n<p>volume status while</p>\\n\\n<p>taking oral diuretics for</p>\\n\\n<p>at least 24 hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf39ffbc24076a92270eea",
        "5cbf39ffbc24076a92270eec",
        "5cdaaa2957b1db001544d8b8"
      ]
    },
    {
      "id": "5caf91f007881d001522af3f",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf91f007881d001522af3e"
      ]
    },
    {
      "id": "5cbf39ffbc24076a92270eea",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf39ffbc24076a92270ee9"
      ]
    },
    {
      "id": "5caf4f3d07881d001522ac8f",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4f3d07881d001522ac8e"
      ]
    },
    {
      "id": "5cbf3ae8bc24076a92270f4a",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e3e",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3898bc24076a92270e3d"
      ]
    },
    {
      "id": "5caf480e07881d001522ac7d",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf480e07881d001522ac7c"
      ]
    },
    {
      "id": "5cacfd2fd1653882bffcfd44",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cacfd2fd1653882bffcfd43"
      ]
    },
    {
      "id": "5cbf39ffbc24076a92270eec",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf39ffbc24076a92270eeb"
      ]
    },
    {
      "id": "5cdaab267920bd0015e73124",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Does the patient have HFrEF: $(HFrEF_present).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf8b052acfa8001101e408",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An MRA should be initiated. Guidance on initiation and titration of these agents in patients with HFrEF can be found in related <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2e0df561b5e742729b4ff8\\\">UpToDate content</span>.</p>\\n\\n<p>After initiating an MRA, a discharged patient should be monitored carefully for the development of worsening kidney function or hyperkalemia.</p>\\n\"",
        "resourceIds": "[\"5d2e0df561b5e742729b4ff8\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdd9f5f64dab00011f81e83",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdd9f5f64dab00011f81e82"
      ]
    },
    {
      "id": "5ce6a815b5c7c8a0fa3bdfb6",
      "metadata": {
        "resourceId": "\"5ce6a815b5c7c8a0fa3bdfb7\"",
        "contentId": "52683",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"New York Heart Association (NYHA) functional class\"",
        "url": "\"https://qawww.utdlab.com/contents/image?imageKey=ID/52683&source=icg&topicId=120904\"",
        "resourceType": "\"utd-Graphic\""
      },
      "tags": [
        "resource",
        "utd-Graphic"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e48",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3899bc24076a92270e47"
      ]
    },
    {
      "id": "5cad091baa11590010e31627",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Does the patient have one or more reasons to have an echocardiogram performed during this hospitalization?</strong></p>\\n\"",
        "variable": "\"Reason_echo\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Reason to obtain an</p>\\n\\n<p>echocardiogram during</p>\\n\\n<p>this admission?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cad091baa11590010e3162a",
        "5cad0baeaa11590010e3162c",
        "5caf3680c2b59b001152b6c5",
        "5cb0a248f6e0b60013cc31b5"
      ]
    },
    {
      "id": "5cbf3a03bc24076a92270f2b",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4894c2b59b001152b6f0"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bd7",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37e719dc0b497eb29bd6"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bd4",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37e819dc0b497eb29bdb"
      ]
    },
    {
      "id": "5caf897afb724bd988d1186a",
      "metadata": {
        "resourceId": "\"5caf897afb724bd988d1186b\"",
        "contentId": "52683",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"NYHA functional class\"",
        "url": "\"https://qawww.utdlab.com/contents/image?imageKey=ID/52683&source=icg&topicId=120904\"",
        "resourceType": "\"utd-Graphic\""
      },
      "tags": [
        "resource",
        "utd-Graphic"
      ]
    },
    {
      "id": "5cbf37ed19dc0b497eb29c1e",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ed19dc0b497eb29c1d"
      ]
    },
    {
      "id": "5cbf37ed19dc0b497eb29c23",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ed19dc0b497eb29c22"
      ]
    },
    {
      "id": "5cdab6007920bd0015e73246",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Is the patient already being treated with an MRA: $(taking_MRA_2).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf4894c2b59b001152b6f3",
      "metadata": {
        "isSummaryLink": "false",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4894c2b59b001152b6f0"
      ]
    },
    {
      "id": "5cdab5a17920bd0015e73244",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Is the patient already being treated with an MRA: $(taking_MRA).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3894bc24076a92270df8",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3894bc24076a92270df9"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdd7",
      "metadata": {
        "resourceId": "\"5cacf86f21c1f40010d2fdd8\"",
        "text": "\"Authors and Editors\"",
        "url": "\"https://qawww.utdlab.com/pathway/120904/contributors\"",
        "resourceType": "\"utd-authors\""
      },
      "tags": [
        "utd-authors",
        "resource"
      ]
    },
    {
      "id": "5cbf3894bc24076a92270dfc",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "true",
        "questionForChildren": "\"<p><strong>Does the patient have any of the above reasons to undergo evaluation by an electrophysiologist?</strong></p>\\n\"",
        "variable": "\"EP_indication\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Reason to obtain</p>\\n\\n<p>an EP consult?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3895bc24076a92270e03",
        "5cbf3895bc24076a92270e05",
        "5cbf3895bc24076a92270e07",
        "5cdaa93357b1db001544d8b4"
      ]
    },
    {
      "id": "5caf4f3d07881d001522ac8c",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":-1}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is the patient being treated with a beta blocker?</strong></p>\\n\"",
        "variable": "\"taking_BB_3\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient</p>\\n\\n<p>being treated with</p>\\n\\n<p>a beta blocker?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf4f3d07881d001522ac8f",
        "5caf520bc2b59b001152b6fd",
        "5caf521207881d001522ac99",
        "5cdab0957920bd0015e73135"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e7d",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394cbc24076a92270e87",
        "5cbf7f302acfa8001101e3f5"
      ]
    },
    {
      "id": "5cbf3a04bc24076a92270f3b",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Some patients with HFrEF who are treated with both a beta blocker and an ARNI, ACE inhibitor, or ARB should also receive an MRA to improve morbidity and mortality. Specifically:</p>\\n\\n<ul>\\n   <li>Patients with ejection fraction &lt;35% who have <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5ce6a7a3b5c7c8a0fa3bdfb5\\\">New York Heart Association (NYHA) functional class</span> II, III, or IV heart failure.</li>\\n   <li>Patients with ejection fraction &le;40% who have had an ST-elevation MI and who also have either NYHA class II, III, or IV heart failure or diabetes mellitus.</li>\\n</ul>\\n\\n<p>In these patients who are admitted for acute heart failure, an MRA should generally be initiated unless one or more of the following apply:</p>\\n\\n<ul>\\n   <li>The patient underwent temporary discontinuation or dose reduction, during the hospitalization, of their ARNI, ACE inhibitor, or ARB.</li>\\n   <li>The patient underwent temporary discontinuation or dose reduction of their beta blocker.</li>\\n   <li>The patient has an estimated glomerular filtration rate (eGFR) &le;30 mL/min/1.73 m<sup>2</sup>.</li>\\n   <li>The patient has a serum potassium &ge;5.0 mEq/L.</li>\\n   <li>The patient has a known intolerance to MRAs.</li>\\n</ul>\\n\"",
        "resourceIds": "[\"5ce6a7a3b5c7c8a0fa3bdfb5\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf849c2acfa8001101e3fd",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf849c2acfa8001101e3fc"
      ]
    },
    {
      "id": "5caf4429c2b59b001152b6e5",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf4429c2b59b001152b6e4"
      ]
    },
    {
      "id": "5cbf39ffbc24076a92270ee8",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf39ffbc24076a92270ee7"
      ]
    },
    {
      "id": "5caf8416c2b59b001152b844",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8416c2b59b001152b843"
      ]
    },
    {
      "id": "5caf3924c2b59b001152b6cb",
      "metadata": {
        "isSummaryLink": "false",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf3924c2b59b001152b6c8"
      ]
    },
    {
      "id": "5caf36a307881d001522ac72",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdabb3eec199540a8d2dffe",
      "metadata": {
        "resourceId": "\"5cdabb3eec199540a8d2dfff\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "921",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Implantable cardioverter-defibrillators: Overview of indications, components, and functions\"",
        "url": "\"https://qawww.utdlab.com/contents/921?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cdaacb47920bd0015e7312c",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with an ARNI, ACE inhibitor, or ARB to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\\n<p>Is the patient being treated with an ARNI, ACE inhibitor, or ARB: $(taking_RAS_2).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e7e",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394cbc24076a92270e7d"
      ]
    },
    {
      "id": "5caf8c05c2b59b001152b918",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate an MRA</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf8c05c2b59b001152b91b",
        "5cbf83ab305efe0016a09a63"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270eaa",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394fbc24076a92270ea9"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270ef5",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf39ffbc24076a92270ef4"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e2b",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3897bc24076a92270e2a"
      ]
    },
    {
      "id": "5caf94be07881d001522af42",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>The patient is</p>\\n\\n<p>suitable for discharge</p>\\n\\n<p>after vaccination</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf94be07881d001522af45",
        "5cbf7a11305efe0016a09a59"
      ]
    },
    {
      "id": "5d2dc980ce3b2f16b037a821",
      "metadata": {
        "resourceId": "\"5d2dc980ce3b2f16b037a822\"",
        "contentId": "52683",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"NYHA functional class\"",
        "url": "\"https://qawww.utdlab.com/contents/image?imageKey=ID/52683&source=icg&topicId=120904\"",
        "resourceType": "\"utd-Graphic\""
      },
      "tags": [
        "resource",
        "utd-Graphic"
      ]
    },
    {
      "id": "5ce822f438e9311ed81f1c5d",
      "metadata": {
        "resourceId": "\"5ce822f438e9311ed81f1c5e\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "86003",
        "isOriginalDescription": "true",
        "active": "true",
        "text": "\"Patient education: Heart failure with preserved ejection fraction (The Basics)\"",
        "url": "\"https://qawww.utdlab.com/contents/86003?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-PAT\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5ced4a394b3c091fb06e8c7b",
      "metadata": {
        "resourceId": "\"5ced4a394b3c091fb06e8c7c\"",
        "displayTag": "\"2\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "120488",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"pneumococcus\"",
        "url": "\"https://qawww.utdlab.com/pathway/120488?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-Pathway\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf37e919dc0b497eb29bea",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37e919dc0b497eb29be9"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e0e",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3895bc24076a92270e0d"
      ]
    },
    {
      "id": "5cdd9d1b27e26e00102e4f28",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdd9d1b27e26e00102e4f27"
      ]
    },
    {
      "id": "5cbf7f89305efe0016a09a5c",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous diuretics to manage their hypervolemia are at higher risk for recurrent acute heart failure as an outpatient and therefore are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3950bc24076a92270eba",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf394fbc24076a92270eb9"
      ]
    },
    {
      "id": "5cbf389bbc24076a92270e61",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf389bbc24076a92270e60"
      ]
    },
    {
      "id": "5cbf3950bc24076a92270ebe",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>A beta blocker should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of beta blockers in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacfd2fd1653882bffcfd47",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ee19dc0b497eb29c2c",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate an MRA</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ef19dc0b497eb29c32"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c15",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient being treated with an MRA?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ed19dc0b497eb29c23",
        "5cbf37ed19dc0b497eb29c25",
        "5cbf37ee19dc0b497eb29c27"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e45",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Consult a heart</p>\\n\\n<p>failure specialist</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf389abc24076a92270e54",
        "5cbf389abc24076a92270e55"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e8b",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394cbc24076a92270e8a"
      ]
    },
    {
      "id": "5caf3ded07881d001522ac78",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf3ded07881d001522ac7b",
        "5cbf7f402acfa8001101e3f7"
      ]
    },
    {
      "id": "5cdabd02ec199540a8d2e01f",
      "metadata": {
        "resourceId": "\"5cdabd02ec199540a8d2e020\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "86147",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Patient education: Heart failure with reduced ejection fraction (The Basics)\"",
        "url": "\"https://qawww.utdlab.com/contents/86147?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-PAT\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf85b1305efe0016a09a6b",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf85b1305efe0016a09a6a"
      ]
    },
    {
      "id": "5cacfd2fd1653882bffcfd3f",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Serial serum creatinine values (to determine the trend in kidney function) and serial serum electrolytes (ie, sodium, potassium) are required to answer the questions that will follow.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf84af07881d001522ae0d",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf84af07881d001522ae0c"
      ]
    },
    {
      "id": "5caf3df4c2b59b001152b6cd",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf3df4c2b59b001152b6cc"
      ]
    },
    {
      "id": "5caf4815c2b59b001152b6ed",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf4815c2b59b001152b6ec"
      ]
    },
    {
      "id": "5cbf3950bc24076a92270ebf",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3950bc24076a92270ebe"
      ]
    },
    {
      "id": "5cdab11d57b1db001544d8c6",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab11d57b1db001544d8c5"
      ]
    },
    {
      "id": "5cdabd10ec199540a8d2e021",
      "metadata": {
        "resourceId": "\"5cdabd10ec199540a8d2e022\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "16189",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Patient education: Medicines for heart failure with reduced ejection fraction (The Basics)\"",
        "url": "\"https://qawww.utdlab.com/contents/16189?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-PAT\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5caf3fa7c2b59b001152b6d4",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf3fa7c2b59b001152b6d7",
        "5cbf7f89305efe0016a09a5d"
      ]
    },
    {
      "id": "5cbf37ed19dc0b497eb29c21",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ed19dc0b497eb29c20"
      ]
    },
    {
      "id": "5cad0baeaa11590010e3162b",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "hideQuestionAnswersBlock": "true",
        "shortTitle": "\"\"",
        "title": "\"<p>Transthoracic</p>\\n\\n<p>echocardiogram recommended</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cad0baeaa11590010e3162e",
        "5cad0c09a23d7e0015f1ad43",
        "5cf7d6c39a45f75a032fca43"
      ]
    },
    {
      "id": "5cdabb77ec199540a8d2e004",
      "metadata": {
        "resourceId": "\"5cdabb77ec199540a8d2e005\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "91077",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Primary prevention of sudden cardiac death in heart failure and cardiomyopathy\"",
        "url": "\"https://qawww.utdlab.com/contents/91077?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf394bbc24076a92270e75",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient been treated with oral diuretics (without any intravenous diuretic therapy) for at least 24 hours, and is the volume status stable or improving?</strong></p>\\n\"",
        "variable": "\"volume_stable_better_24_2\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Stable or improving</p>\\n\\n<p>volume status while</p>\\n\\n<p>taking oral diuretics for</p>\\n\\n<p>at least 24 hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394cbc24076a92270e7c",
        "5cbf394cbc24076a92270e7e",
        "5cdaaaaa7920bd0015e73123"
      ]
    },
    {
      "id": "5cdab27757b1db001544d8ce",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab27757b1db001544d8cd"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f25",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270ef7",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a00bc24076a92270ef6"
      ]
    },
    {
      "id": "5caf363207881d001522ac6b",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf363107881d001522ac6a"
      ]
    },
    {
      "id": "5cad091baa11590010e31628",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cad091baa11590010e31627"
      ]
    },
    {
      "id": "5cdaacd97920bd0015e7312e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with an ARNI, ACE inhibitor, or ARB to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\\n<p>Is the patient being treated with an ARNI, ACE inhibitor, or ARB: $(taking_RAS_3).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e07",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3895bc24076a92270e06"
      ]
    },
    {
      "id": "5cbf3898bc24076a92270e3d",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An ARNI, ACE inhibitor, or ARB should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of these drugs in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdab35057b1db001544d92b",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab35057b1db001544d92a"
      ]
    },
    {
      "id": "5cbf89e22acfa8001101e407",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf89e22acfa8001101e406"
      ]
    },
    {
      "id": "5caf32d84ac0c658ab9bf262",
      "metadata": {
        "resourceId": "\"5caf32d84ac0c658ab9bf263\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "946",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"survived an episode of SCD\"",
        "url": "\"https://qawww.utdlab.com/contents/946?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf3898bc24076a92270e32",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient tolerated the beta blocker for at least several hours?</strong></p>\\n\"",
        "variable": "\"BB_tolerate_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Has the patient tolerated</p>\\n\\n<p>the beta blocker for</p>\\n\\n<p>at least several hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3899bc24076a92270e40",
        "5cbf3899bc24076a92270e42",
        "5cbf3899bc24076a92270e44",
        "5cdd9f5f64dab00011f81e83"
      ]
    },
    {
      "id": "5ced4b192d0120d50eba49d2",
      "metadata": {
        "resourceId": "\"5ced4b192d0120d50eba49d3\"",
        "displayTag": "\"2\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "120488",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"pneumococcus\"",
        "url": "\"https://qawww.utdlab.com/pathway/120488?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-Pathway\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5caf4815c2b59b001152b6ee",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An ARNI, ACE inhibitor, or ARB should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of these drugs in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacfd2fd1653882bffcfd3e",
      "metadata": {
        "isSummaryLink": "false",
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cacfd2ed1653882bffcfd3d"
      ]
    },
    {
      "id": "5caf8c0c07881d001522af3d",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf8c0c07881d001522af3c"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c0b",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ed19dc0b497eb29c1c"
      ]
    },
    {
      "id": "5cdab7577920bd0015e7324e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Some patients with HFrEF who are treated with both a beta blocker and an ARNI, ACE inhibitor, or ARB should also receive an MRA to improve morbidity and mortality. Specifically:</p>\\n\\n<ul>\\n   <li>Patients with ejection fraction &lt;35% who have <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf897afb724bd988d1186b\\\">NYHA functional class</span> II, III, or IV heart failure.</li>\\n   <li>Patients with ejection fraction &le;40% who have had an ST-elevation MI and who also have either NYHA class II, III, or IV heart failure or diabetes mellitus.</li>\\n</ul>\\n\\n<p>In these patients who are admitted for acute heart failure, an MRA should generally be initiated unless one or more of the following apply:</p>\\n\\n<ul>\\n   <li>The patient underwent temporary discontinuation or dose reduction, during the hospitalization, of their ARNI, ACE inhibitor, or ARB.</li>\\n   <li>The patient underwent temporary discontinuation or dose reduction of their beta blocker.</li>\\n   <li>The patient has an eGFR &le;30 mL/min/1.73 m<sup>2</sup>.</li>\\n   <li>The patient has a serum potassium &ge;5.0 mEq/L.</li>\\n   <li>The patient has a known intolerance to MRAs.</li>\\n</ul>\\n\\n<p>Should the patient be initiated on an MRA: $(MRA_indicated_3).</p>\\n\"",
        "resourceIds": "[\"5caf897afb724bd988d1186b\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bfe",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ea19dc0b497eb29bfd"
      ]
    },
    {
      "id": "5cbf3951bc24076a92270ec8",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaaa2857b1db001544d8b7",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient been treated with oral diuretics (without any intravenous diuretic therapy) for at least 24 hours, and is the volume status stable or improving: $(volume_stable_better_24).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cb0a09621c262c35a0e0651",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cacf86f21c1f40010d2fdcb"
      ]
    },
    {
      "id": "5cb08ca6b9e5980010e9fcd4",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cb08ca6b9e5980010e9fcd7",
        "5cbf7b0b305efe0016a09a5b"
      ]
    },
    {
      "id": "5cdabcb0ec199540a8d2e01b",
      "metadata": {
        "resourceId": "\"5cdabcb0ec199540a8d2e01c\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "16443",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Patient education: Heart failure and atrial fibrillation (The Basics)\"",
        "url": "\"https://qawww.utdlab.com/contents/16443?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-PAT\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5caf38154ac0c658ab9bf28a",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cad0bc4aa11590010e3162f"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e03",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3895bc24076a92270e02"
      ]
    },
    {
      "id": "5cbf3a01bc24076a92270f10",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF who are hospitalized for acute heart failure and who are unable to tolerate treatment with an ARNI, ACE inhibitor, or ARB should be evaluated by a heart failure specialist before discharge to help navigate treatment options.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e7a",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf394bbc24076a92270e79"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270f03",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a00bc24076a92270f02"
      ]
    },
    {
      "id": "5cacfd2ed1653882bffcfd3b",
      "metadata": {
        "title": "\"\"",
        "content": "\"<h4><strong>Scope</strong></h4>\\n\\n<p>This UpToDate Pathway will help clinicians determine whether or not a patient admitted to the hospital for acute decompensated heart failure is ready to be discharged.<br />\\n<br />\\nThe use of this UpToDate Pathway is <strong>not</strong> intended for patients with acute decompensated heart failure who have a mechanical circulatory assist device or a cardiac transplant. This UpToDate Pathway is also <strong>not</strong> appropriate for patients receiving continuous or intermittent renal replacement therapy.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f18",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a02bc24076a92270f17"
      ]
    },
    {
      "id": "5caf358b4ac0c658ab9bf268",
      "metadata": {
        "resourceId": "\"5caf358b4ac0c658ab9bf269\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "977",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"poorly controlled atrial fibrillation\"",
        "url": "\"https://qawww.utdlab.com/contents/977?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5caf4acdec403d1d8127a2eb",
      "metadata": {
        "resourceId": "\"5caf4acdec403d1d8127a2ec\"",
        "headingReferenceId": "\"H17676495\"",
        "contentId": "105338",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"topics\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=105338&Bookmark=H17676495\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c0e",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c0d"
      ]
    },
    {
      "id": "5cb08ca6b9e5980010e9fcd5",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cb08ca6b9e5980010e9fcd4"
      ]
    },
    {
      "id": "5cbf3b60bc24076a92270f53",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cdab6aa7920bd0015e7324a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Some patients with HFrEF who are treated with both a beta blocker and an ARNI, ACE inhibitor, or ARB should also receive an MRA to improve morbidity and mortality. Specifically:</p>\\n\\n<ul>\\n   <li>Patients with ejection fraction &lt;35% who have <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2c9fc9ab650a0a4300b3ac\\\">NYHA functional class</span> II, III, or IV heart failure.</li>\\n   <li>Patients with ejection fraction &le;40% who have had an ST-elevation MI and who also have either NYHA class II, III, or IV heart failure or diabetes mellitus.</li>\\n</ul>\\n\\n<p>In these patients who are admitted for acute heart failure, an MRA should generally be initiated unless one or more of the following apply:</p>\\n\\n<ul>\\n   <li>The patient underwent temporary discontinuation or dose reduction, during the hospitalization, of their ARNI, ACE inhibitor, or ARB.</li>\\n   <li>The patient underwent temporary discontinuation or dose reduction of their beta blocker.</li>\\n   <li>The patient has an eGFR &le;30 mL/min/1.73 m<sup>2</sup>.</li>\\n   <li>The patient has a serum potassium &ge;5.0 mEq/L.</li>\\n   <li>The patient has a known intolerance to MRAs.</li>\\n</ul>\\n\\n<p>Should the patient be initiated on an MRA: $(MRA_indicated).</p>\\n\"",
        "resourceIds": "[\"5d2c9fc9ab650a0a4300b3ac\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdabd1bec199540a8d2e026",
      "metadata": {
        "resourceId": "\"5cdabd1bec199540a8d2e025\"",
        "title": "\"utd-society-guidelines-section\"",
        "sectionType": "\"utd-society-guidelines-section\"",
        "content": "\"<ul>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cdabd6cec199540a8d2e029\\\">Society guideline links: Heart failure in adults</span></li>\\n</ul>\\n\"",
        "resourceIds": "[\"5cdabd6cec199540a8d2e029\"]",
        "resourceType": "\"section\""
      },
      "tags": [
        "resource",
        "section",
        "utd-society-guidelines-section"
      ]
    },
    {
      "id": "5cbf3898bc24076a92270e36",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with a beta blocker to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should generally be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf87ac07881d001522af2b",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf87ac07881d001522af2a"
      ]
    },
    {
      "id": "5cbf394bbc24076a92270e71",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394bbc24076a92270e72"
      ]
    },
    {
      "id": "5caf363e07881d001522ac6e",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e84",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaae8a7920bd0015e73131",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaae897920bd0015e73130"
      ]
    },
    {
      "id": "5cacfe30a23d7e0015f1ad3a",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdab17657b1db001544d8ca",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab17657b1db001544d8c9"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f21",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is the patient already being treated with a mineralocorticoid receptor antagonist (MRA)?</strong></p>\\n\"",
        "variable": "\"taking_MRA\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient being</p>\\n\\n<p>treated with an MRA?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3b60bc24076a92270f53",
        "5cbf3a03bc24076a92270f31",
        "5cdab5a27920bd0015e73245"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e28",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":1}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3898bc24076a92270e39",
        "5cbf875c305efe0016a09a6f"
      ]
    },
    {
      "id": "5caf3fa7c2b59b001152b6d7",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf3fa7c2b59b001152b6d6"
      ]
    },
    {
      "id": "5cdab6267920bd0015e73249",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab6257920bd0015e73248"
      ]
    },
    {
      "id": "5d2dce116219ae73dc8cd543",
      "metadata": {
        "resourceId": "\"5d2dce116219ae73dc8cd544\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "921",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"ICD\"",
        "url": "\"https://qawww.utdlab.com/contents/921?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf3898bc24076a92270e39",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3898bc24076a92270e38"
      ]
    },
    {
      "id": "5caf4f3707881d001522ac8a",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c0d",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>In patients with HFrEF, beta blockers may cause hypoperfusion and bradycardia. If a beta blocker is newly initiated or resumed after discontinuation, the patient should be monitored for these potential complications for at least 24 hours.</p>\\n\\n<p><strong>Has the patient tolerated the beta blocker for at least 24 hours?</strong></p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdd9d7a27e26e00102e4f2a",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdd9d7a27e26e00102e4f29"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e51",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking a beta blocker for only a few hours should be monitored for hypotension and bradycardia before discharge is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c14",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c13"
      ]
    },
    {
      "id": "5cdab7c057b1db001544d9be",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Certain clinical criteria should be satisfied before determining that a patient hospitalized for acute heart failure is suitable for discharge. These include:</p>\\n\\n<ul>\\n   <li>The patient's symptoms (ie, the symptoms of acute heart failure that prompted hospitalization) have improved. As an example, a patient who was too dyspneic to ambulate at the time of hospitalization should be able to ambulate at the time of discharge (unless there is an orthopedic problem interfering with ambulation).</li>\\n   <li>The patient's blood pressure should be controlled, but the patient should not have symptomatic hypotension.</li>\\n   <li>The patient's electrolytes (in particular, potassium, sodium, magnesium) should be normal (or in an acceptable range and either stable or improving) for at least 24 hours.</li>\\n   <li>The patient's kidney function should be stable for at least 24 hours or improving.</li>\\n</ul>\\n\\n<p>Are these clinical criteria for discharge satisfied: $(clin_crit).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ed19dc0b497eb29c26",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Is the patient already being treated with a mineralocorticoid receptor blocker (MRA)?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a01bc24076a92270f0c",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with a beta blocker to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should generally be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e4b",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is the patient already being treated with a mineralocorticoid receptor antagonist (MRA)?</strong></p>\\n\"",
        "variable": "\"taking_MRA_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient being</p>\\n\\n<p>treated with an MRA?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3bbfbc24076a92270f5d",
        "5cbf389abc24076a92270e5b",
        "5cdab5d857b1db001544d9bb"
      ]
    },
    {
      "id": "5cbf3950bc24076a92270ebb",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF who are hospitalized for acute heart failure and who are unable to tolerate treatment with a beta blocker (even at a low dose) should be evaluated by a heart failure specialist before discharge to help navigate treatment options.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaaebf7920bd0015e73133",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaaebf7920bd0015e73132"
      ]
    },
    {
      "id": "5d025097caa878f8603cb5a2",
      "metadata": {
        "resourceId": "\"5d025097caa878f8603cb5a3\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3475",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"CRT\"",
        "url": "\"https://qawww.utdlab.com/contents/3475?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5caf3680c2b59b001152b6c4",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "true",
        "questionForChildren": "\"<p><strong>Has the patient already been evaluated by an electrophysiology (EP) specialist for ICD or CRT?</strong></p>\\n\"",
        "variable": "\"EP_consult_already_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Has the patient had</p>\\n\\n<p>an EP consult?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394bbc24076a92270e71",
        "5caf38154ac0c658ab9bf28a",
        "5cdaa8e87920bd0015e73121",
        "5ce459c4a5a9440015d9da5d"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270eb9",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking a beta blocker for only a few hours should be monitored for hypotension and bradycardia before discharge is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf8a89305efe0016a09a7d",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf8a89305efe0016a09a7c"
      ]
    },
    {
      "id": "5caf8416c2b59b001152b845",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3896bc24076a92270e19",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "true",
        "questionForChildren": "\"<p><strong>Is the patient being treated with one of these medications?</strong></p>\\n\"",
        "variable": "\"taking_RAS_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient being</p>\\n\\n<p>treated with an ARNI,</p>\\n\\n<p>ACE inhibitor, or ARB?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3897bc24076a92270e21",
        "5cbf3897bc24076a92270e23",
        "5cbf3897bc24076a92270e25",
        "5cdaac837920bd0015e7312b"
      ]
    },
    {
      "id": "5caf4430c2b59b001152b6e9",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf4430c2b59b001152b6e8"
      ]
    },
    {
      "id": "5caf944dfb724bd988d11887",
      "metadata": {
        "resourceId": "\"5caf944dfb724bd988d11888\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "7021",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"pneumococcus \"",
        "url": "\"https://qawww.utdlab.com/contents/7021?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cdabb9fec199540a8d2e00a",
      "metadata": {
        "resourceId": "\"5cdabb9fec199540a8d2e00b\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3454",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Treatment of acute decompensated heart failure: General considerations\"",
        "url": "\"https://qawww.utdlab.com/contents/3454?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf37eb19dc0b497eb29c05",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37eb19dc0b497eb29c04"
      ]
    },
    {
      "id": "5caf480e07881d001522ac7e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF who are hospitalized for acute heart failure and who are unable to tolerate treatment with an ARNI, ACE inhibitor, or ARB should be evaluated by a heart failure specialist before discharge to help navigate treatment options.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e24",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with an angiotensin receptor-neprilysin inhibitor (ARNI), angiotensin-converting enzyme (ACE) inhibitor, or angiotensin receptor blocker (ARB) to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5ced48cbf5bc96001112f309",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient received intravenous inotropes or vasodilators during the previous 24 hours: $(inotropes_yes_2).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5ced4853f5bc96001112f306",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5ced4853f5bc96001112f305"
      ]
    },
    {
      "id": "5d2cda47d2eeaad4d3417477",
      "metadata": {
        "resourceId": "\"5d2cda47d2eeaad4d3417478\"",
        "contentId": "52683",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"NYHA functional class\"",
        "url": "\"https://qawww.utdlab.com/contents/image?imageKey=ID/52683&source=icg&topicId=120904\"",
        "resourceType": "\"utd-Graphic\""
      },
      "tags": [
        "resource",
        "utd-Graphic"
      ]
    },
    {
      "id": "5caf3df4c2b59b001152b6ce",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf91f7c2b59b001152b91f",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf91f7c2b59b001152b91e"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270ea9",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3950bc24076a92270eba",
        "5cbf8523305efe0016a09a69"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29be4",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cdaab9657b1db001544d8be",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaab9657b1db001544d8bd"
      ]
    },
    {
      "id": "5ce459c4a5a9440015d9da5c",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>It is good practice to consider cardiac resynchronization therapy (CRT) or an implantable cardioverter-defibrillator (ICD) in certain patients who have heart failure with reduced ejection fraction (HFrEF).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacfd2fd1653882bffcfd40",
      "metadata": {
        "isSummaryLink": "false",
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cacfd2fd1653882bffcfd3f"
      ]
    },
    {
      "id": "5caf8b6c07881d001522af39",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf8b6c07881d001522af38"
      ]
    },
    {
      "id": "5cbf3c58bc24076a92270f78",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cdab80a7920bd0015e73250",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with heart failure should receive vaccinations against <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5ced4b192d0120d50eba49d3\\\">pneumococcus</span> and <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf9494fb724bd988d1188a\\\">seasonal influenza</span>. Has the patient already received these vaccinations, if appropriate: $(vaccinated).</p>\\n\"",
        "resourceIds": "[\"5ced4b192d0120d50eba49d3\",\"5caf9494fb724bd988d1188a\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf84f9305efe0016a09a67",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf84f9305efe0016a09a66"
      ]
    },
    {
      "id": "5cdaabb87920bd0015e73128",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Does the patient have HFrEF: $(HFrEF_present_3).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a03bc24076a92270f29",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF who are hospitalized for acute heart failure and who are unable to tolerate treatment with a beta blocker (even at a low dose) should be evaluated by a heart failure specialist before discharge to help navigate treatment options.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5ce457b42f86000015eaf1d1",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>It is good practice to consider cardiac resynchronization therapy (CRT) or an implantable cardioverter-defibrillator (ICD) in certain patients who have heart failure with reduced ejection fraction.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ed19dc0b497eb29c22",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "title": "\"Fill in Node Title\""
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ee19dc0b497eb29c2b"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e8c",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with an angiotensin receptor-neprilysin inhibitor (ARNI), angiotensin-converting enzyme (ACE) inhibitor, or angiotensin receptor blocker (ARB) to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5ce561a503fc410b66035a07",
      "metadata": {
        "resourceId": "\"5ce561a503fc410b66035a08\"",
        "headingReferenceId": "\"H15\"",
        "contentId": "3464",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"content\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=3464&Bookmark=H15\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cdaa8e87920bd0015e73120",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient already been evaluated by an EP specialist: $(EP_consult_already_1).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3896bc24076a92270e14",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3896bc24076a92270e13"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f1e",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a02bc24076a92270f1d"
      ]
    },
    {
      "id": "5ce6b39f409cdb9b34732b8d",
      "metadata": {
        "resourceId": "\"5ce6b39f409cdb9b34732b8e\"",
        "contentId": "52683",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"New York Heart Association (NYHA) functional class\"",
        "url": "\"https://qawww.utdlab.com/contents/image?imageKey=ID/52683&source=icg&topicId=120904\"",
        "resourceType": "\"utd-Graphic\""
      },
      "tags": [
        "resource",
        "utd-Graphic"
      ]
    },
    {
      "id": "5caf8c0c07881d001522af3b",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cbf37e619dc0b497eb29bc9",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3896bc24076a92270e1a",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3896bc24076a92270e19"
      ]
    },
    {
      "id": "5caf849a07881d001522ae0a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF who are hospitalized for acute heart failure and who are unable to tolerate treatment with a beta blocker (even at a low dose) should be evaluated by a heart failure specialist before discharge to help navigate treatment options.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bf2",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ea19dc0b497eb29bf1"
      ]
    },
    {
      "id": "5cbf37ee19dc0b497eb29c2f",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Some patients with HFrEF who are treated with both a beta blocker and an ARNI, ACE inhibitor, or ARB should also receive an MRA to improve morbidity and mortality. Specifically:</p>\\n\\n<ul>\\n   <li>Patients with ejection fraction &lt;35% who have <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf897afb724bd988d1186b\\\">NYHA functional class</span> II, III, or IV heart failure.</li>\\n   <li>Patients with ejection fraction &le;40% who have had a ST elevation myocardial infarction and who also have either NYHA class II, III, or IV heart failure or diabetes mellitus.</li>\\n</ul>\\n\\n<p>In these patients who are admitted for acute heart failure, an MRA should generally be initiated unless one or more of the following apply:</p>\\n\\n<ul>\\n   <li>The patient underwent temporary discontinuation or dose reduction, during the hospitalization, of their ARNI, ACE inhibitor, or ARB.</li>\\n   <li>The patient underwent temporary discontinuation or dose reduction of their beta blocker.</li>\\n   <li>The patient has an estimated glomerular filtration rate (eGFR) &le;30 mL/min/1.73m<sup>2</sup>.</li>\\n   <li>The patient has a serum potassium &ge;5.0 meq/L.</li>\\n</ul>\\n\\n<p><strong>Based upon the above criteria, should the patient be initiated on an MRA?</strong></p>\\n\"",
        "resourceIds": "[\"5caf897afb724bd988d1186b\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf7f302acfa8001101e3f4",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous diuretics to manage their hypervolemia are at higher risk for recurrent acute heart failure as an outpatient and therefore are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf41d7c2b59b001152b6dd",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf41d7c2b59b001152b6dc"
      ]
    },
    {
      "id": "5caf521207881d001522ac99",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf521207881d001522ac98"
      ]
    },
    {
      "id": "5cbf8416305efe0016a09a65",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf8416305efe0016a09a64"
      ]
    },
    {
      "id": "5cdab3787920bd0015e731e0",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Is a beta blocker not being used because the patient has active bronchospasm, because the patient has a hypersensitivity to beta blockers, or because, after it was introduced, it produced hypoperfusion or bradycardia: $(no_BB_reason_2).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e0f",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf86b42acfa8001101e400",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bd1",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>The patient has one or more reasons to be evaluated by an electrophysiologist. An EP consultation should be obtained prior to discharging the patient.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf4429c2b59b001152b6e6",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>In patients with HFrEF, ARNIs, ACE inhibitors, and ARBs may produce hypotension, impaired kidney function, and/or hyperkalemia. If one of these agents is newly initiated or resumed after discontinuation, the patient should be monitored at least several hours for the development of hypotension and should have outpatient follow-up of electrolytes and kidney function within one to two weeks.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394bbc24076a92270e72",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient received intravenous inotropes or vasodilators during the previous 24 hours?</strong></p>\\n\"",
        "variable": "\"inotropes_yes_2\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Received IV</p>\\n\\n<p>inotropes or vasodilators</p>\\n\\n<p>in the previous 24 hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394bbc24076a92270e74",
        "5cbf394bbc24076a92270e76",
        "5ced48cbf5bc96001112f30a"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270f04",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate (or resume)</p>\\n\\n<p>therapy with an ARNI,</p>\\n\\n<p>ACE inhibitor, or ARB</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a02bc24076a92270f14",
        "5cbf8994305efe0016a09a79"
      ]
    },
    {
      "id": "5cbf8a89305efe0016a09a7c",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking a beta blocker for less than 24 hours should be monitored for adverse effects, including hypoperfusion and bradycardia, before discharge from the hospital is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf94b5c2b59b001152b921",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf94b5c2b59b001152b920"
      ]
    },
    {
      "id": "5d2e2b6ec95553ffb5bdad71",
      "metadata": {
        "resourceId": "\"5d2e2b6ec95553ffb5bdad72\"",
        "headingReferenceId": "\"H15\"",
        "contentId": "3464",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"UpToDate content\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=3464&Bookmark=H15\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5caf3ded07881d001522ac79",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf3ded07881d001522ac78"
      ]
    },
    {
      "id": "5cf7d545b8e74100125bf53d",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf4815c2b59b001152b6ec",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate (or resume)</p>\\n\\n<p>therapy with an ARNI,</p>\\n\\n<p>ACE inhibitor, or ARB</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf4815c2b59b001152b6ef",
        "5cbf80d5305efe0016a09a5f"
      ]
    },
    {
      "id": "5caf94be07881d001522af45",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf94be07881d001522af44"
      ]
    },
    {
      "id": "5cad091baa11590010e3162a",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cad091baa11590010e31629"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270eae",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394fbc24076a92270ead"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e42",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3899bc24076a92270e41"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e09",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3895bc24076a92270e08"
      ]
    },
    {
      "id": "5cbf84f9305efe0016a09a66",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>A beta blocker should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of beta blockers in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bf6",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ea19dc0b497eb29bf5"
      ]
    },
    {
      "id": "5cbf3950bc24076a92270ec3",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3950bc24076a92270ec2"
      ]
    },
    {
      "id": "5caf94be07881d001522af44",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>The patient should be vaccinated against pneumococcus and/or seasonal influenza. Guidance on administration of these vaccines can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf95aefb724bd988d11894\\\">topics</span> and in separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf9590fb724bd988d11892\\\">Pathways</span>.</p>\\n\\n<p>After appropriate vaccinations are given, the patient can be discharged. Using a <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cb09c1621c262c35a0e0645\\\">discharge checklist</span> may help reduce the likelihood of readmission for recurrent heart failure.</p>\\n\"",
        "resourceIds": "[\"5caf95aefb724bd988d11894\",\"5caf9590fb724bd988d11892\",\"5cb09c1621c262c35a0e0645\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29bdc",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Does the patient have HFrEF?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37e819dc0b497eb29be3",
        "5cbf37e819dc0b497eb29be4",
        "5cbf37e919dc0b497eb29be6"
      ]
    },
    {
      "id": "5cbf3896bc24076a92270e12",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3896bc24076a92270e11"
      ]
    },
    {
      "id": "5cdaa98f57b1db001544d8b5",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Consultation with an EP specialist to consider indications for an <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2dce116219ae73dc8cd544\\\">ICD</span> or for <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2dce206219ae73dc8cd546\\\">CRT</span> is suggested for:</p>\\n\\n<ul>\\n   <li>Patients with HFrEF, an ejection fraction &le;35%, and <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2dce486219ae73dc8cd54c\\\">NYHA functional class</span> II or III.</li>\\n   <li>Patients with HFrEF, a history of ischemic heart disease, an ejection fraction &le;35%, and NYHA class I, II, or III.</li>\\n   <li>Patients with HFrEF, an ejection fraction &le;35%, a QRS duration &ge;120 milliseconds, and NYHA class IV.</li>\\n   <li>Patients who have survived an episode of SCD (prior to or during this hospitalization).</li>\\n   <li>Patients with a history of sustained VT.</li>\\n   <li>Patients with an ischemic heart disease and unexplained syncope.</li>\\n   <li>Patients with NYHA class III or IV who have a QRS duration &ge;150 milliseconds and LBBB.</li>\\n   <li>Patients with atrial fibrillation in whom rhythm and/or rate control has proven difficult to attain.</li>\\n</ul>\\n\\n<p>Does the patient have any of the above reasons to undergo evaluation by an electrophysiologist: $(EP_indication_1).</p>\\n\"",
        "resourceIds": "[\"5d2dce116219ae73dc8cd544\",\"5d2dce206219ae73dc8cd546\",\"5d2dce486219ae73dc8cd54c\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacfd2fd1653882bffcfd48",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cacfd2fd1653882bffcfd47"
      ]
    },
    {
      "id": "5ced48ebf5bc96001112f30c",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5ced48ebf5bc96001112f30b"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f17",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a03bc24076a92270f28",
        "5cbf8a89305efe0016a09a7d"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270eb7",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf389abc24076a92270e56",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>A beta blocker should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of beta blockers in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5d2e2be1c95553ffb5bdad7d",
      "metadata": {
        "resourceId": "\"5d2e2be1c95553ffb5bdad7e\"",
        "headingReferenceId": "\"H15\"",
        "contentId": "3464",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"UpToDate content\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=3464&Bookmark=H15\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf3951bc24076a92270ecd",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Some patients with HFrEF who are treated with both a beta blocker and an ARNI, ACE inhibitor, or ARB should also receive an MRA to improve morbidity and mortality. Specifically:</p>\\n\\n<ul>\\n   <li>Patients with ejection fraction &lt;35% who have <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5ce6b390409cdb9b34732b8c\\\">New York Heart Association (NYHA) functional class</span> II, III, or IV heart failure.</li>\\n   <li>Patients with ejection fraction &le;40% who have had an ST-elevation myocardial infarction (MI) and who also have either NYHA class II, III, or IV heart failure or diabetes mellitus.</li>\\n</ul>\\n\\n<p>In these patients who are admitted for acute heart failure, an MRA should generally be initiated unless one or more of the following apply:</p>\\n\\n<ul>\\n   <li>The patient underwent temporary discontinuation or dose reduction, during the hospitalization, of their ARNI, ACE inhibitor, or ARB.</li>\\n   <li>The patient underwent temporary discontinuation or dose reduction of their beta blocker.</li>\\n   <li>The patient has an estimated glomerular filtration rate (eGFR) &le;30 mL/min/1.73 m<sup>2</sup>.</li>\\n   <li>The patient has a serum potassium &ge;5.0 mEq/L.</li>\\n   <li>The patient has a known intolerance to MRAs.</li>\\n</ul>\\n\"",
        "resourceIds": "[\"5ce6b390409cdb9b34732b8c\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaaaaa7920bd0015e73123",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaaaaa7920bd0015e73122"
      ]
    },
    {
      "id": "5caf841bc2b59b001152b847",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf841bc2b59b001152b84a",
        "5cbf82f5305efe0016a09a61"
      ]
    },
    {
      "id": "5cbf3a01bc24076a92270f0d",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a01bc24076a92270f0c"
      ]
    },
    {
      "id": "5cdab3a357b1db001544d943",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Is a beta blocker not being used because the patient has active bronchospasm, because the patient has a hypersensitivity to beta blockers, or because, after it was introduced, it produced hypoperfusion or bradycardia: $(no_BB_reason_3).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f22",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a02bc24076a92270f21"
      ]
    },
    {
      "id": "5d2dce2c6219ae73dc8cd547",
      "metadata": {
        "resourceId": "\"5d2dce2c6219ae73dc8cd548\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3475",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"CRT\"",
        "url": "\"https://qawww.utdlab.com/contents/3475?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e43",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>In patients with HFrEF, beta blockers may cause hypoperfusion and bradycardia. If a beta blocker is newly initiated or resumed after discontinuation, the patient should be monitored for at least several hours for these potential complications.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bf5",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Consult a heart failure specialist</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37eb19dc0b497eb29c05",
        "5cbf37eb19dc0b497eb29c06"
      ]
    },
    {
      "id": "5cbf7a10305efe0016a09a58",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>The patient should be vaccinated against pneumococcus and/or seasonal influenza. Guidance on administration of these vaccines can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf95aefb724bd988d11894\\\">topics</span> and in separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf9590fb724bd988d11892\\\">Pathways</span>.</p>\\n\\n<p>After appropriate vaccinations are given, the patient can be discharged. Using a <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cb09c1621c262c35a0e0645\\\">discharge checklist</span> may help reduce the likelihood of readmission for recurrent heart failure.</p>\\n\"",
        "resourceIds": "[\"5caf95aefb724bd988d11894\",\"5caf9590fb724bd988d11892\",\"5cb09c1621c262c35a0e0645\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdd9fac27e26e00102e4f2b",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient tolerated the beta blocker for at least several hours: $(BB_tolerate_3).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e4c",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3899bc24076a92270e4b"
      ]
    },
    {
      "id": "5cbf3896bc24076a92270e13",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Does the patient have heart failure with reduced ejection fraction (</strong><strong>HFrEF)?</strong></p>\\n\"",
        "variable": "\"HFrEF_present_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Does the patient</p>\\n\\n<p>have HFrEF?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3896bc24076a92270e1a",
        "5cbf3896bc24076a92270e1b",
        "5cdaab567920bd0015e73127"
      ]
    },
    {
      "id": "5cbf37ee19dc0b497eb29c2b",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ee19dc0b497eb29c2a"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c17",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "title": "\"Fill in Node Title\""
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ee19dc0b497eb29c29"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdce",
      "metadata": {
        "shortLabel": "\"<p>&nbsp;&nbsp;</p>\\n\"",
        "title": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cacf86f21c1f40010d2fdd0"
      ]
    },
    {
      "id": "5cbf80d5305efe0016a09a5e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An ARNI, ACE inhibitor, or ARB should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of these drugs in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f15",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>This patient is taking an ARNI, ACE inhibitor, or ARB and is also taking a beta blocker. Have these drugs been continued, without interruption or dose reduction, since prior to hospitalization?</strong></p>\\n\"",
        "variable": "\"ARNI_BB_prior\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Beta blocker and ARNI,</p>\\n\\n<p>ACE inhibitor, or ARB</p>\\n\\n<p>continued at same doses</p>\\n\\n<p>since before hospitalization?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a02bc24076a92270f22",
        "5cbf3ae8bc24076a92270f4a",
        "5cdab47f7920bd0015e73241"
      ]
    },
    {
      "id": "5ce6aaa9725210fb6c1b7567",
      "metadata": {
        "resourceId": "\"5ce6aaa9725210fb6c1b7568\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3475",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"CRT\"",
        "url": "\"https://qawww.utdlab.com/contents/3475?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e9d",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394dbc24076a92270e9c"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e86",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous diuretics within the last 24 hours to manage their hypervolemia are at higher risk for recurrent acute heart failure as an outpatient and therefore are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c08",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37eb19dc0b497eb29c07"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270efe",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":1}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a01bc24076a92270f0f",
        "5cbf89e22acfa8001101e407"
      ]
    },
    {
      "id": "5caf36aa07881d001522ac77",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf36aa07881d001522ac76"
      ]
    },
    {
      "id": "5caf4815c2b59b001152b6ef",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4815c2b59b001152b6ee"
      ]
    },
    {
      "id": "5cacfd2fd1653882bffcfd49",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bd0",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37e719dc0b497eb29bcf"
      ]
    },
    {
      "id": "5cbf3a01bc24076a92270f09",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a01bc24076a92270f08"
      ]
    },
    {
      "id": "5cb087647002070be1d00179",
      "metadata": {
        "resourceId": "\"5cb087647002070be1d0017a\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3498",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Acute coronary syndrome\"",
        "url": "\"https://qawww.utdlab.com/contents/3498?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf394ebc24076a92270ea0",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking an ARNI, ACE inhibitor, or ARB for only a few hours should be monitored for hypotension before discharge is considered. Arrangements also need to be made to monitor for worsening kidney function or a concerning rise in serum potassium after the patient is discharged from the hospital.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaac837920bd0015e7312a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with an ARNI, ACE inhibitor, or ARB to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\\n<p>Is the patient being treated with an ARNI, ACE inhibitor, or ARB: $(taking_RAS_1).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf3fd7140af18331430e4c",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf3fd7140af18331430e4b"
      ]
    },
    {
      "id": "5cdab4f657b1db001544d9b7",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab4f657b1db001544d9b6"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdd0",
      "metadata": {
        "layout": "{\"width\":180,\"height\":60,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Did the patient have one or more of these precipitating factors leading to hospitalization for acute heart failure?</strong></p>\\n\"",
        "isChildrenHidden": "false",
        "variable": "\"acute_disorder\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Precipitating factor</p>\\n\\n<p>leading to admission for</p>\\n\\n<p>acute heart failure?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cacf86f21c1f40010d2fdc2",
        "5cacf86f21c1f40010d2fdc4",
        "5cacf86f21c1f40010d2fdca",
        "5cdaa55f57b1db001544d8b0"
      ]
    },
    {
      "id": "5cbf3951bc24076a92270eca",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate an MRA</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3952bc24076a92270ed0",
        "5cbf85b1305efe0016a09a6b"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270f00",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>In patients with HFrEF, ARNIs, ACE inhibitors, and ARBs may produce hypotension, impaired kidney function, and/or hyperkalemia. If one of these agents is newly initiated or resumed after discontinuation, the patient should be monitored at least several hours for the development of hypotension and should have outpatient follow-up of electrolytes and kidney function within one to two weeks.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacfd2ed1653882bffcfd3c",
      "metadata": {
        "isSummaryLink": "false",
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cacfd2ed1653882bffcfd3b"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e44",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3899bc24076a92270e43"
      ]
    },
    {
      "id": "5cbf394ebc24076a92270ea4",
      "metadata": {
        "isSummaryLink": "false",
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4894c2b59b001152b6f0"
      ]
    },
    {
      "id": "5cbf37e919dc0b497eb29be6",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37e819dc0b497eb29be5"
      ]
    },
    {
      "id": "5caf4b5f07881d001522ac83",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4b5f07881d001522ac82"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e26",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":-1}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is the patient being treated with a beta blocker?</strong></p>\\n\"",
        "variable": "\"taking_BB_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient</p>\\n\\n<p>being treated with</p>\\n\\n<p>a beta blocker?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3898bc24076a92270e33",
        "5cbf3898bc24076a92270e35",
        "5cbf3898bc24076a92270e37",
        "5cdab14c57b1db001544d8c8"
      ]
    },
    {
      "id": "5cdd9da164dab00011f81e7d",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdd9da164dab00011f81e7c"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bcd",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Received intravenous inotropes or vasodilators in the previous 24 hours?&nbsp;</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37e719dc0b497eb29bd5",
        "5cbf37e719dc0b497eb29bd7",
        "5cbf37e819dc0b497eb29bd9"
      ]
    },
    {
      "id": "5cbf39ffbc24076a92270ee7",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous inotropes or intravenous vasodilators to manage their heart failure within the last 24 hours are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf7e362acfa8001101e3f2",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous inotropes or intravenous vasodilators to manage their heart failure are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdab4f657b1db001544d9b6",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>This patient is taking an ARNI, ACE inhibitor, or ARB and is also taking a beta blocker. Have these drugs been continued, without interruption or dose reduction, since prior to hospitalization: $(ARNI_BB_prior_2).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf94b6c2b59b001152b923",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf94b5c2b59b001152b922"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270ea7",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>This patient is taking an ARNI, ACE inhibitor, or ARB and is also taking a beta blocker. Have these drugs been continued, without interruption or dose reduction, since prior to hospitalization?</strong></p>\\n\"",
        "variable": "\"ARNI_BB_prior_2\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Beta blocker and ARNI,</p>\\n\\n<p>ACE inhibitor, or ARB</p>\\n\\n<p>continued at same doses</p>\\n\\n<p>since before hospitalization?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394fbc24076a92270eb4",
        "5cbf3bebbc24076a92270f62",
        "5cdab4f657b1db001544d9b7"
      ]
    },
    {
      "id": "5caf8b4e07881d001522af35",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf8b4e07881d001522af34"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e8a",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is an ARNI, ACE inhibitor, or ARB not being used for one or both of the following reasons?</strong></p>\\n\\n<ul>\\n   <li>The patient developed an adverse effect from the drug (ie, hypotension, worsening kidney function, or hyperkalemia).</li>\\n   <li>The patient has a history of angioedema or hypersensitivity to ARNIs or ACE inhibitors and has an allergy to single-agent ARBs.</li>\\n</ul>\\n\"",
        "variable": "\"no_ARNI_reason_2\"",
        "shortTitle": "\"\"",
        "title": "\"<p>ARNI, ACE inhibitor,</p>\\n\\n<p>or ARB not being used</p>\\n\\n<p>due to intolerance?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394dbc24076a92270e95",
        "5cbf394dbc24076a92270e97",
        "5cdaaebf7920bd0015e73133"
      ]
    },
    {
      "id": "5caf91f7c2b59b001152b91e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients hospitalized for acute heart failure should not be discharged if they have had no symptomatic improvement, have uncontrolled hypertension, have concerning electrolyte abnormalities, or have worsening kidney function.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e95",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394dbc24076a92270e94"
      ]
    },
    {
      "id": "5cdaab567920bd0015e73126",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Does the patient have HFrEF: $(HFrEF_present_1).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e0b",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3896bc24076a92270e12",
        "5cbf864f2acfa8001101e3ff"
      ]
    },
    {
      "id": "5ced48a0f5bc96001112f308",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5ced48a0f5bc96001112f307"
      ]
    },
    {
      "id": "5cb089d57002070be1d0018d",
      "metadata": {
        "resourceId": "\"5cb089d57002070be1d0018e\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "977",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Atrial fibrillation\"",
        "url": "\"https://qawww.utdlab.com/contents/977?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf3952bc24076a92270ece",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3951bc24076a92270ecd"
      ]
    },
    {
      "id": "5cdaa93357b1db001544d8b4",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaa93357b1db001544d8b3"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e02",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "hideQuestionAnswersBlock": "true",
        "shortTitle": "\"\"",
        "title": "\"<p>EP consult suggested</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3895bc24076a92270e09",
        "5cbf3895bc24076a92270e0a",
        "5cf7ecc2253119bbb12d8b6a"
      ]
    },
    {
      "id": "5caf4b6607881d001522ac86",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking an ARNI, ACE inhibitor, or ARB for only a few hours should be monitored for hypotension before discharge is considered. Arrangements also need to be made to monitor for worsening kidney function or a concerning rise in serum potassium after the patient is discharged from the hospital.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf8cbafb724bd988d1187c",
      "metadata": {
        "resourceId": "\"5caf8cbafb724bd988d1187d\"",
        "headingReferenceId": "\"H17677523\"",
        "contentId": "105338",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"topics\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=105338&Bookmark=H17677523\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf394ebc24076a92270ea1",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf394ebc24076a92270ea0"
      ]
    },
    {
      "id": "5cbf39ffbc24076a92270eed",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e0d",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient been treated with oral diuretics (without any intravenous diuretic therapy) for at least 24 hours, and is the volume status stable or improving?</strong></p>\\n\"",
        "variable": "\"volume_stable_better_24_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Stable or improving</p>\\n\\n<p>volume status while</p>\\n\\n<p>taking oral diuretics for</p>\\n\\n<p>at least 24 hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3896bc24076a92270e14",
        "5cbf3896bc24076a92270e16",
        "5cdaaa7557b1db001544d8ba"
      ]
    },
    {
      "id": "5caf94be07881d001522af43",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf94be07881d001522af42"
      ]
    },
    {
      "id": "5cbf39febc24076a92270ee2",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf39febc24076a92270ee1"
      ]
    },
    {
      "id": "5cb0892c7002070be1d00183",
      "metadata": {
        "resourceId": "\"5cb0892c7002070be1d00184\"",
        "headingReferenceId": "\"H70455727\"",
        "contentId": "3837",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"immediate goal\"",
        "url": "\"https://qawww.utdlab.com/contents/3837?source=icg&topicId=120904&anchor=H70455727#H70455727\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cdd9fac27e26e00102e4f2c",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdd9fac27e26e00102e4f2b"
      ]
    },
    {
      "id": "5cbf39febc24076a92270ee4",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf39febc24076a92270ee3"
      ]
    },
    {
      "id": "5cbf39ffbc24076a92270ef4",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous diuretics within the last 24 hours to manage their hypervolemia are at higher risk for recurrent acute heart failure as an outpatient and therefore are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c09",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Beta blocker and ARNI, ACE inhibitor, or ARB continued at same doses since before hospitalization?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c16",
        "5cbf37ec19dc0b497eb29c18",
        "5cbf37ec19dc0b497eb29c1a"
      ]
    },
    {
      "id": "5ce45693a5a9440015d9da5a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Obtaining an echocardiogram is good practice in some patients hospitalized for acute heart failure, such as in those without a prior echocardiogram.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3894bc24076a92270dfe",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaacd97920bd0015e7312f",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaacd97920bd0015e7312e"
      ]
    },
    {
      "id": "5cbf394bbc24076a92270e79",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous inotropes or intravenous vasodilators to manage their heart failure within the last 24 hours are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a01bc24076a92270f0a",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is a beta blocker not being used because the patient has active bronchospasm, because the patient has a hypersensitivity to beta blockers, or because, after it was introduced, it produced hypoperfusion or bradycardia?</strong></p>\\n\"",
        "variable": "\"no_BB_reason\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Beta blocker not</p>\\n\\n<p>being used because</p>\\n\\n<p>of intolerance?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a02bc24076a92270f1c",
        "5cbf3a02bc24076a92270f1e",
        "5cdab27757b1db001544d8ce"
      ]
    },
    {
      "id": "5cb09b2d21c262c35a0e0641",
      "metadata": {
        "resourceId": "\"5cb09b2d21c262c35a0e0642\"",
        "displayTag": "\"2\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "120885",
        "isOriginalDescription": "true",
        "active": "true",
        "text": "\"Acute decompensated heart failure: Discharge checklist\"",
        "url": "\"https://qawww.utdlab.com/pathway/120885?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-Pathway\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5ce45694a5a9440015d9da5b",
      "metadata": {
        "isSummaryLink": "false",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5ce45693a5a9440015d9da5a"
      ]
    },
    {
      "id": "5cdab52957b1db001544d9b8",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>This patient is taking an ARNI, ACE inhibitor, or ARB and is also taking a beta blocker. Have these drugs been continued, without interruption or dose reduction, since prior to hospitalization: $(ARNI_BB_prior_3).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaac1357b1db001544d8bf",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with an ARNI, ACE inhibitor, or ARB to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\\n<p>Is the patient being treated with an ARNI, ACE inhibitor, or ARB: $(taking_RAS).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3896bc24076a92270e16",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3896bc24076a92270e15"
      ]
    },
    {
      "id": "5caf3ded07881d001522ac7a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous inotropes or intravenous vasodilators to manage their heart failure within the last 24 hours are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf79d42acfa8001101e3f0",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients hospitalized for acute heart failure should not be discharged if they've had no symptomatic improvement, have uncontrolled hypertension, have concerning electrolyte abnormalities, or have worsening kidney function.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf7b0b305efe0016a09a5b",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf7b0b305efe0016a09a5a"
      ]
    },
    {
      "id": "5caf520bc2b59b001152b6fc",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient tolerated the beta blocker for at least several hours?</strong></p>\\n\"",
        "variable": "\"BB_tolerate_3\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Has the patient tolerated</p>\\n\\n<p>the beta blocker for</p>\\n\\n<p>at least several hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf520bc2b59b001152b6ff",
        "5caf8416c2b59b001152b844",
        "5caf841bc2b59b001152b848",
        "5cdd9fac27e26e00102e4f2c"
      ]
    },
    {
      "id": "5cdd9f3064dab00011f81e80",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient tolerated the beta blocker for at least several hours: $(BB_tolerate).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf4aebec403d1d8127a2ed",
      "metadata": {
        "resourceId": "\"5caf4aebec403d1d8127a2ee\"",
        "displayTag": "\"2\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "120051",
        "active": "false",
        "isOriginalDescription": "false",
        "text": "\"Pathway\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=120051&Bookmark=H00\"",
        "resourceType": "\"utd-Pathway\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf871e2acfa8001101e403",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf871e2acfa8001101e402"
      ]
    },
    {
      "id": "5cbf88e62acfa8001101e404",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous inotropes or intravenous vasodilators to manage their heart failure are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3898bc24076a92270e3b",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3898bc24076a92270e3a"
      ]
    },
    {
      "id": "5cbf3898bc24076a92270e34",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is a beta blocker not being used because the patient has active bronchospasm, because the patient has a hypersensitivity to beta blockers, or because, after it was introduced, it produced hypoperfusion or bradycardia?</strong></p>\\n\"",
        "variable": "\"no_BB_reason_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Beta blocker not</p>\\n\\n<p>being used because</p>\\n\\n<p>of intolerance?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3899bc24076a92270e46",
        "5cbf3899bc24076a92270e48",
        "5cdab35057b1db001544d92b"
      ]
    },
    {
      "id": "5caf84af07881d001522ae0e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>A beta blocker should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of beta blockers in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf87bb305efe0016a09a71",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf87bb305efe0016a09a70"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e0c",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3895bc24076a92270e0b"
      ]
    },
    {
      "id": "5cbf3a03bc24076a92270f28",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a02bc24076a92270f27"
      ]
    },
    {
      "id": "5cbf37ee19dc0b497eb29c2e",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5caf8b6c07881d001522af37",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8b6c07881d001522af36"
      ]
    },
    {
      "id": "5d2dce206219ae73dc8cd545",
      "metadata": {
        "resourceId": "\"5d2dce206219ae73dc8cd546\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3475",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"CRT\"",
        "url": "\"https://qawww.utdlab.com/contents/3475?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf389abc24076a92270e55",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4894c2b59b001152b6f0"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bfc",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ea19dc0b497eb29bfb"
      ]
    },
    {
      "id": "5cb09b1a21c262c35a0e063f",
      "metadata": {
        "resourceId": "\"5cb09b1a21c262c35a0e0640\"",
        "displayTag": "\"2\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "120051",
        "isOriginalDescription": "true",
        "active": "false",
        "text": "\"Heart failure with preserved ejection fraction (HFpEF): Initial pharmacologic therapy and dose titration for patients with compensated HFpEF\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=120051&Bookmark=H00\"",
        "resourceType": "\"utd-Pathway\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf3951bc24076a92270ecc",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cdab80a7920bd0015e73251",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab80a7920bd0015e73250"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bf0",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ea19dc0b497eb29bef"
      ]
    },
    {
      "id": "5cacfd2ed1653882bffcfd3d",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>This UpToDate Pathway <strong>is not</strong> appropriate for patients with any of the following exclusions:</p>\\n\\n<ul>\\n   <li>Age &lt;18 years</li>\\n   <li>Pregnant</li>\\n   <li>Patient with a mechanical circulatory assist device</li>\\n   <li>Patient with a cardiac transplantation</li>\\n   <li>Patient receiving continuous or intermittent renal replacement therapy</li>\\n</ul>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270eb4",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394fbc24076a92270eb3"
      ]
    },
    {
      "id": "5caf8c05c2b59b001152b91a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An MRA should be initiated. Guidance on initiation and titration of these agents in patients with HFrEF can be found in related <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2e2bbfc95553ffb5bdad7c\\\">UpToDate content</span>.</p>\\n\\n<p>After initiating an MRA, a discharged patient should be monitored carefully for the development of worsening kidney function or hyperkalemia.</p>\\n\"",
        "resourceIds": "[\"5d2e2bbfc95553ffb5bdad7c\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270efc",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":-1}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is the patient being treated with a beta blocker?</strong></p>\\n\"",
        "variable": "\"taking_BB\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient</p>\\n\\n<p>being treated with</p>\\n\\n<p>a beta blocker?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a01bc24076a92270f09",
        "5cbf3a01bc24076a92270f0b",
        "5cbf3a01bc24076a92270f0d",
        "5cdab11d57b1db001544d8c6"
      ]
    },
    {
      "id": "5caf33114ac0c658ab9bf264",
      "metadata": {
        "resourceId": "\"5caf33114ac0c658ab9bf265\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "946",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"survived an episode of cardiac arrest\"",
        "url": "\"https://qawww.utdlab.com/contents/946?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cdaa98f57b1db001544d8b6",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaa98f57b1db001544d8b5"
      ]
    },
    {
      "id": "5cbf37eb19dc0b497eb29c06",
      "metadata": {
        "isSummaryLink": "false",
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4894c2b59b001152b6f0"
      ]
    },
    {
      "id": "5cdab6fb7920bd0015e7324d",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab6fb7920bd0015e7324c"
      ]
    },
    {
      "id": "5caf480e07881d001522ac7c",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Consult a heart</p>\\n\\n<p>failure specialist</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf480e07881d001522ac7f",
        "5caf4894c2b59b001152b6f3"
      ]
    },
    {
      "id": "5cdaa83d57b1db001544d8b1",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient already been evaluated by an EP specialist: $(EP_consult_already).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bf3",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>In patients with HFrEF, ARNIs, ACE inhibitors, and ARBs may produce hypotension, impaired kidney function, and/or hyperkalemia. If one of these agents is newly initiated or resumed after discontinuation, the patient should be monitored for these potential complications for at least 24 hours.</p>\\n\\n<p><strong>Has the patient tolerated the ARNI, ACE inhibitor, or ARB for at least 24 hours without developing hypotension, worsening kidney function, or a concerning rise in serum potassium?</strong></p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c1b",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking an beta blocker for less than 24 hours should be monitored for adverse effects, including hypoperfusion and bradycardia, before discharge from the hospital is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e0a",
      "metadata": {
        "isSummaryLink": "false",
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf3924c2b59b001152b6c8"
      ]
    },
    {
      "id": "5cb09c1621c262c35a0e0644",
      "metadata": {
        "resourceId": "\"5cb09c1621c262c35a0e0645\"",
        "displayTag": "\"2\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "120885",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"discharge checklist\"",
        "url": "\"https://qawww.utdlab.com/pathway/120885?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-Pathway\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e8e",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":-1}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is the patient being treated with a beta blocker?</strong></p>\\n\"",
        "variable": "\"taking_BB_2\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient</p>\\n\\n<p>being treated with</p>\\n\\n<p>a beta blocker?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394dbc24076a92270e9b",
        "5cbf394dbc24076a92270e9d",
        "5cbf394ebc24076a92270e9f",
        "5cdab17657b1db001544d8ca"
      ]
    },
    {
      "id": "5cbf3a03bc24076a92270f31",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a03bc24076a92270f30"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270ead",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Consult a heart</p>\\n\\n<p>failure specialist</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3950bc24076a92270ebc",
        "5cbf3950bc24076a92270ebd"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270f02",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Consult a heart</p>\\n\\n<p>failure specialist</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a01bc24076a92270f11",
        "5cbf3a01bc24076a92270f12"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e88",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient's blood pressure tolerated the ARNI, ACE inhibitor, or ARB, and have arrangements been made to monitor as an outpatient for worsening kidney function or a concerning rise in serum potassium?</strong></p>\\n\"",
        "variable": "\"BP_stable_ACE_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Stable blood pressure on ARNI, ACE inhibitor,</p>\\n\\n<p>and outpatient laboratory</p>\\n\\n<p>follow-up arranged?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394dbc24076a92270e8f",
        "5cbf394dbc24076a92270e91",
        "5cbf394dbc24076a92270e93",
        "5cdd9d7a27e26e00102e4f2a"
      ]
    },
    {
      "id": "5cbf3bebbc24076a92270f62",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cdaab9657b1db001544d8bd",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Does the patient have HFrEF: $(HFrEF_present_2).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf39febc24076a92270ee0",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient received intravenous inotropes or vasodilators during the previous 24 hours?</strong></p>\\n\"",
        "variable": "\"inotropes_yes\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Received IV</p>\\n\\n<p>inotropes or vasodilators</p>\\n\\n<p>in the previous 24 hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf39febc24076a92270ee2",
        "5cbf39febc24076a92270ee4",
        "5ced4853f5bc96001112f306"
      ]
    },
    {
      "id": "5cbf37e919dc0b497eb29beb",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>ARNI, ACE inhibitor, or ARB not being used due to intolerance?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ea19dc0b497eb29bf6",
        "5cbf37ea19dc0b497eb29bf8",
        "5cbf37ea19dc0b497eb29bfa"
      ]
    },
    {
      "id": "5caf480e07881d001522ac7f",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf480e07881d001522ac7e"
      ]
    },
    {
      "id": "5cbf3a04bc24076a92270f38",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate an MRA</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a04bc24076a92270f3e",
        "5cbf8b052acfa8001101e409"
      ]
    },
    {
      "id": "5cbf389bbc24076a92270e66",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf389bbc24076a92270e65"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29be0",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient been treated with oral diuretics (without any intravenous diuretic therapy) for at least 24 hours, and is the volume status stable or improving?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdab14c57b1db001544d8c8",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab14c57b1db001544d8c7"
      ]
    },
    {
      "id": "5cdaadd857b1db001544d8c1",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>ARNIs, ACE inhibitors, and ARBs are often avoided if one or both of the following are present:</p>\\n\\n<ul>\\n   <li>The patient developed an adverse effect from the drug (ie, hypotension, worsening kidney function, or hyperkalemia).</li>\\n   <li>The patient has a history of angioedema or hypersensitivity to ARNIs or ACE inhibitors and has an allergy to single-agent ARBs.</li>\\n</ul>\\n\\n<p>Is an ARNI, ACE inhibitor, or ARB not being used for one or both of these reasons: $(no_ARNI_reason).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a04bc24076a92270f37",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a04bc24076a92270f36"
      ]
    },
    {
      "id": "5cbf37eb19dc0b497eb29c02",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking an ARNI, ACE inhibitor, or ARB for less than 24 hours should be monitored for adverse effects, including hypotension, worsening kidney function, and a concerning rise in serum potassium, before discharge from the hospital is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3c44bc24076a92270f73",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cbf39ffbc24076a92270eeb",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a00bc24076a92270ef5",
        "5cbf891b305efe0016a09a77"
      ]
    },
    {
      "id": "5cb0898b7002070be1d0018b",
      "metadata": {
        "resourceId": "\"5cb0898b7002070be1d0018c\"",
        "headingReferenceId": "\"H1246074216\"",
        "contentId": "3497",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"severe hypertension\"",
        "url": "\"https://qawww.utdlab.com/contents/3497?source=icg&topicId=120904&anchor=H1246074216#H1246074216\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bcc",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37e719dc0b497eb29bcb"
      ]
    },
    {
      "id": "5caf87b207881d001522af30",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacfd2ed1653882bffcfd39",
      "metadata": {
        "layout": "{\"width\":180,\"height\":60,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "title": "\"Fill in Node Title\""
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cacfd2fd1653882bffcfd44",
        "5cacfd2fd1653882bffcfd46",
        "5cacfd2fd1653882bffcfd48"
      ]
    },
    {
      "id": "5cb0a4c5f6e0b60013cc31b7",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cb0a4c5f6e0b60013cc31b6"
      ]
    },
    {
      "id": "5cbf394ebc24076a92270ea5",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An ARNI, ACE inhibitor, or ARB should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of these drugs in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdd9a0d64dab00011f81e7a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient's precipitating disorder (or disorders) been suitably treated: $(suitable_rx).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaaa7557b1db001544d8b9",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient been treated with oral diuretics (without any intravenous diuretic therapy) for at least 24 hours, and is the volume status stable or improving: $(volume_stable_better_24_1).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a03bc24076a92270f2d",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a03bc24076a92270f2c"
      ]
    },
    {
      "id": "5cdab3787920bd0015e731e1",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab3787920bd0015e731e0"
      ]
    },
    {
      "id": "5cbf3a01bc24076a92270f12",
      "metadata": {
        "isSummaryLink": "false",
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4894c2b59b001152b6f0"
      ]
    },
    {
      "id": "5caf3fa7c2b59b001152b6d6",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous diuretics within the last 24 hours to manage their hypervolemia are at higher risk for recurrent acute heart failure as an outpatient and therefore are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bcb",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Order EP consult</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37e719dc0b497eb29bd2",
        "5cbf37e719dc0b497eb29bd3"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e30",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>&nbsp;</p>\\n\\n<ul>\\n</ul>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c0a",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c09"
      ]
    },
    {
      "id": "5cdaadd857b1db001544d8c2",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaadd857b1db001544d8c1"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f1c",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a02bc24076a92270f1b"
      ]
    },
    {
      "id": "5cbf37e919dc0b497eb29be8",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37e919dc0b497eb29be7"
      ]
    },
    {
      "id": "5cbf37ed19dc0b497eb29c1f",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4894c2b59b001152b6f0"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f1f",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf7f89305efe0016a09a5d",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf7f89305efe0016a09a5c"
      ]
    },
    {
      "id": "5cbf8994305efe0016a09a78",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An ARNI, ACE inhibitor, or ARB should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of these drugs in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdd4",
      "metadata": {
        "title": "\"\"",
        "content": "\"<h4><strong>Scope</strong></h4>\\n\\n<p>This UpToDate Pathway will help clinicians determine whether a patient admitted to the hospital for acute decompensated heart failure is ready to be discharged.</p>\\n\\n<p>The use of this UpToDate Pathway is <strong>not</strong> intended for patients with acute decompensated heart failure who have a mechanical circulatory assist device or a cardiac transplant. This UpToDate Pathway is also <strong>not</strong> appropriate for patients receiving continuous or intermittent renal replacement therapy.</p>\\n\\n<p>This UpToDate Pathway may be used repeatedly for the same patient until criteria for discharge are attained.</p>\\n\\n<p>Related UpToDate Pathways:</p>\\n\\n<ul>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cb09b0521c262c35a0e063e\\\">Heart failure: Selecting the site of care from the emergency department</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cb09b1a21c262c35a0e0640\\\">Heart failure with preserved ejection fraction (HFpEF): Initial pharmacologic therapy and dose titration for patients with compensated HFpEF</span></li>\\n   <li><span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cb09b2d21c262c35a0e0642\\\">Acute decompensated heart failure: Discharge checklist</span></li>\\n</ul>\\n\"",
        "resourceIds": "[\"5cb09b0521c262c35a0e063e\",\"5cb09b1a21c262c35a0e0640\",\"5cb09b2d21c262c35a0e0642\"]"
      },
      "tags": [
        "searchable",
        "content"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bd6",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Stable or improving volume status while taking oral diuretics for at least 24 hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37e819dc0b497eb29bdd",
        "5cbf37e819dc0b497eb29bdf",
        "5cbf37e819dc0b497eb29be1"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270efd",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a00bc24076a92270efc"
      ]
    },
    {
      "id": "5cad0bc4aa11590010e3162f",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Does the patient have any of the above reasons to undergo evaluation by an electrophysiologist?</strong></p>\\n\"",
        "variable": "\"EP_indication_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Reason to obtain</p>\\n\\n<p>an EP consult?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cad0bc4aa11590010e31632",
        "5caf363107881d001522ac69",
        "5caf363e07881d001522ac6d",
        "5cdaa98f57b1db001544d8b6"
      ]
    },
    {
      "id": "5cbf389abc24076a92270e5e",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3952bc24076a92270ecf",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An MRA should be initiated. Guidance on initiation and titration of these agents in patients with HFrEF can be found in related <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2e2b6ec95553ffb5bdad72\\\">UpToDate content</span>.</p>\\n\\n<p>After initiating an MRA, a discharged patient should be monitored carefully for the development of worsening kidney function or hyperkalemia.</p>\\n\"",
        "resourceIds": "[\"5d2e2b6ec95553ffb5bdad72\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf389abc24076a92270e5b",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf389abc24076a92270e5a"
      ]
    },
    {
      "id": "5caf41d7c2b59b001152b6de",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with an angiotensin receptor-neprilysin inhibitor (ARNI), angiotensin-converting enzyme (ACE) inhibitor, or angiotensin receptor blocker (ARB) to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a03bc24076a92270f2c",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>A beta blocker should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of beta blockers in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e27",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3897bc24076a92270e26"
      ]
    },
    {
      "id": "5cad0911a23d7e0015f1ad3f",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cad0911a23d7e0015f1ad3e"
      ]
    },
    {
      "id": "5cbf37eb19dc0b497eb29c01",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ea19dc0b497eb29bff"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e94",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Consult a heart</p>\\n\\n<p>failure specialist</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394ebc24076a92270ea3",
        "5cbf394ebc24076a92270ea4"
      ]
    },
    {
      "id": "5cbf3ba4bc24076a92270f58",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bef",
      "metadata": {
        "layout": "{\"width\":null,\"height\":null,\"offsetNodeByY\":0,\"offsetNodeByX\":-1}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient being treated with a beta blocker?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ea19dc0b497eb29bfc",
        "5cbf37ea19dc0b497eb29bfe",
        "5cbf37eb19dc0b497eb29c01"
      ]
    },
    {
      "id": "5cbf389abc24076a92270e5a",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Based upon the above criteria, should the patient be initiated on an MRA?</strong></p>\\n\"",
        "variable": "\"MRA_indicated_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Should an MRA</p>\\n\\n<p>be initiated?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf389bbc24076a92270e63",
        "5cbf389bbc24076a92270e64",
        "5cbf389bbc24076a92270e66",
        "5cdab6fb7920bd0015e7324d"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e2d",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3897bc24076a92270e2c"
      ]
    },
    {
      "id": "5cbf871e2acfa8001101e402",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An ARNI, ACE inhibitor, or ARB should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of these drugs in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bf9",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Is an ARNI, ACE inhibitor, or ARB not being used for one or both of the following reasons?</p>\\n\\n<ul>\\n   <li>The patient developed an adverse effect from the drug (ie, hypotension, worsening kidney function, or hyperkalemia).</li>\\n   <li>The patient has a history of angioedema or hypersensitivity to ARNIs or ACE inhibitors, and has an allergy to single-agent ARBs.</li>\\n</ul>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e8f",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394dbc24076a92270e8e"
      ]
    },
    {
      "id": "5cbf864f2acfa8001101e3fe",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous inotropes or intravenous vasodilators to manage their heart failure are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29be1",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37e819dc0b497eb29be0"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bd5",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37e719dc0b497eb29bd4"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e90",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":1}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394ebc24076a92270ea1",
        "5cbf849c2acfa8001101e3fd"
      ]
    },
    {
      "id": "5caf849a07881d001522ae0b",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf849a07881d001522ae0a"
      ]
    },
    {
      "id": "5cdabb83ec199540a8d2e006",
      "metadata": {
        "resourceId": "\"5cdabb83ec199540a8d2e007\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "977",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"The management of atrial fibrillation in patients with heart failure\"",
        "url": "\"https://qawww.utdlab.com/contents/977?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c0c",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c0b"
      ]
    },
    {
      "id": "5cbf3894bc24076a92270e00",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5d02507acaa878f8603cb5a0",
      "metadata": {
        "resourceId": "\"5d02507acaa878f8603cb5a1\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "921",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"ICD\"",
        "url": "\"https://qawww.utdlab.com/contents/921?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5ce8232038e9311ed81f1c61",
      "metadata": {
        "resourceId": "\"5ce8232038e9311ed81f1c62\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "16189",
        "isOriginalDescription": "true",
        "active": "true",
        "text": "\"Patient education: Medicines for heart failure with reduced ejection fraction (The Basics)\"",
        "url": "\"https://qawww.utdlab.com/contents/16189?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-PAT\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cdab4c87920bd0015e73243",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab4c87920bd0015e73242"
      ]
    },
    {
      "id": "5caf3fd7140af18331430e4b",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous inotropes or intravenous vasodilatores to manage their heart failure are not appropriate to be discharged from the hospital.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bca",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37e619dc0b497eb29bc9"
      ]
    },
    {
      "id": "5cbf8806305efe0016a09a73",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf8806305efe0016a09a72"
      ]
    },
    {
      "id": "5cbf37e919dc0b497eb29bec",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37e919dc0b497eb29beb"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e08",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>The patient has one or more reasons to be evaluated by an electrophysiologist. An EP consultation should be ordered, although this is typically done as an outpatient (arranged prior to discharge).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf875c305efe0016a09a6f",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf875c305efe0016a09a6e"
      ]
    },
    {
      "id": "5cdab0957920bd0015e73135",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab0957920bd0015e73134"
      ]
    },
    {
      "id": "5cbf3896bc24076a92270e1c",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf841bc2b59b001152b848",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf841bc2b59b001152b847"
      ]
    },
    {
      "id": "5caf3ded07881d001522ac7b",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf3ded07881d001522ac7a"
      ]
    },
    {
      "id": "5caf841bc2b59b001152b84a",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf841bc2b59b001152b849"
      ]
    },
    {
      "id": "5cbf3950bc24076a92270ec2",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Based upon the above criteria, should the patient be initiated on an MRA?</strong></p>\\n\"",
        "variable": "\"MRA_indicated_2\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Should an MRA</p>\\n\\n<p>be initiated?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3951bc24076a92270ecb",
        "5cbf3951bc24076a92270ecc",
        "5cbf3952bc24076a92270ece",
        "5cdab72757b1db001544d9bd"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bf7",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate (or resume) therapy with an ARNI, ACE inhibitor, or ARB</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c08"
      ]
    },
    {
      "id": "5cdaa7f27920bd0015e7311e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Was an echocardiogram performed during this hospitalization: $(echo_performed_hosp).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5d2e0f65f9e096b4271168e3",
      "metadata": {
        "resourceId": "\"5d2e0f65f9e096b4271168e4\"",
        "headingReferenceId": "\"H15\"",
        "contentId": "3464",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"UpToDate content\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=3464&Bookmark=H15\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf37ee19dc0b497eb29c28",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e3f",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>This patient is taking an ARNI, ACE inhibitor, or ARB and is also taking a beta blocker. Have these drugs been continued, without interruption or dose reduction, since prior to hospitalization?</strong></p>\\n\"",
        "variable": "\"ARNI_BB_prior_1\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Beta blocker and ARNI,</p>\\n\\n<p>ACE inhibitor, or ARB</p>\\n\\n<p>continued at same doses</p>\\n\\n<p>since before hospitalization?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3899bc24076a92270e4c",
        "5cbf3ba4bc24076a92270f58",
        "5cdab4c87920bd0015e73243"
      ]
    },
    {
      "id": "5ce457b42f86000015eaf1d2",
      "metadata": {
        "isSummaryLink": "false",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5ce457b42f86000015eaf1d1"
      ]
    },
    {
      "id": "5cbf39febc24076a92270ee5",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29be5",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Does the patient have HFrEF?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ed19dc0b497eb29c20",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>A beta blocker should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).\\n\\n<p>Guidance on initiation and titration of beta blockers in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cad091baa11590010e31629",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients should undergo a transthoracic echocardiogram prior to discharge if one or more of the following apply:</p>\\n\\n<ul>\\n   <li>The patient has not previously had an echocardiogram.</li>\\n   <li>The patient's acute decompensation was precipitated, at least in part, by an acute coronary syndrome.</li>\\n   <li>The reason for the patient's acute decompensation is unclear.</li>\\n</ul>\\n\\n<p>In such patients, echocardiographic findings may identify the type of heart failure, the presence of valvular disease, and/or other features that could require treatment before discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3894bc24076a92270dfd",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3894bc24076a92270dfc"
      ]
    },
    {
      "id": "5cbf3951bc24076a92270ec7",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3951bc24076a92270ec6"
      ]
    },
    {
      "id": "5d2e0df561b5e742729b4ff7",
      "metadata": {
        "resourceId": "\"5d2e0df561b5e742729b4ff8\"",
        "headingReferenceId": "\"H15\"",
        "contentId": "3464",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"UpToDate content\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=3464&Bookmark=H15\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf3898bc24076a92270e37",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3898bc24076a92270e36"
      ]
    },
    {
      "id": "5cbf394ebc24076a92270e9f",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf394dbc24076a92270e9e"
      ]
    },
    {
      "id": "5cbf83ab305efe0016a09a62",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An MRA should be initiated. Guidance on initiation and titration of these agents in patients with HFrEF can be found in related <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2e2be1c95553ffb5bdad7e\\\">UpToDate content</span>.</p>\\n\\n<p>After initiating an MRA, a discharged patient should be monitored carefully for the development of worsening kidney function or hyperkalemia.</p>\\n\"",
        "resourceIds": "[\"5d2e2be1c95553ffb5bdad7e\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdd9dc664dab00011f81e7e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient's blood pressure tolerated the ARNI, ACE inhibitor, or ARB, and have arrangements been made to monitor as an outpatient for worsening kidney function or a concerning rise in serum potassium: $(BP_stable_ACE_3).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf91f007881d001522af40",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with heart failure should receive vaccinations against <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5ced4a394b3c091fb06e8c7c\\\">pneumococcus</span> and <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf9494fb724bd988d1188a\\\">seasonal influenza</span>.</p>\\n\"",
        "resourceIds": "[\"5ced4a394b3c091fb06e8c7c\",\"5caf9494fb724bd988d1188a\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdab11d57b1db001544d8c5",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with a beta blocker to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should generally be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\\n<p>Is the patient being treated with a beta blocker: $(taking_BB).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29bd9",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37e719dc0b497eb29bd8"
      ]
    },
    {
      "id": "5cdab47f7920bd0015e73240",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>This patient is taking an ARNI, ACE inhibitor, or ARB and is also taking a beta blocker. Have these drugs been continued, without interruption or dose reduction, since prior to hospitalization: $(ARNI_BB_prior).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaaee157b1db001544d8c4",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaaee157b1db001544d8c3"
      ]
    },
    {
      "id": "5cf7ecc2253119bbb12d8b6a",
      "metadata": {
        "autoRouteFormula": "\"$(EP_consult_ordered) == 1\"",
        "isAutoRouteEnabled": "true",
        "title": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3895bc24076a92270e04"
      ]
    },
    {
      "id": "5cbf3898bc24076a92270e3a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF who are hospitalized for acute heart failure and who are unable to tolerate treatment with an ARNI, ACE inhibitor, or ARB should be evaluated by a heart failure specialist before discharge to help navigate treatment options.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c10",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c0f"
      ]
    },
    {
      "id": "5cad0bc4aa11590010e31632",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cad0bc4aa11590010e31631"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270f06",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>&nbsp;</p>\\n\\n<ul>\\n</ul>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e2f",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3897bc24076a92270e2e"
      ]
    },
    {
      "id": "5cbf3950bc24076a92270ebc",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3950bc24076a92270ebb"
      ]
    },
    {
      "id": "5caf41ddc2b59b001152b6e2",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37e919dc0b497eb29bed",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with either an angiotensin receptor neprilysin inhibitor (ARNI), angiotensin converting enzyme (ACE) inhibitor, or angiotensin receptor blocker (ARB) to improve morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\\n<p><strong>Is the patient being treated with one of these medications?</strong></p>\\n\\n<p>&nbsp;</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270eac",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf394fbc24076a92270eab"
      ]
    },
    {
      "id": "5caf8543fb724bd988d1184b",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf4894c2b59b001152b6f0"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270eb3",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is the patient already being treated with a mineralocorticoid receptor antagonist (MRA)?</strong></p>\\n\"",
        "variable": "\"taking_MRA_2\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient being</p>\\n\\n<p>treated with an MRA?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3c1cbc24076a92270f6e",
        "5cbf3950bc24076a92270ec3",
        "5cdab6007920bd0015e73247"
      ]
    },
    {
      "id": "5cb0a4c5f6e0b60013cc31b6",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>The patient is suitable for discharge. Using a <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cb09c1621c262c35a0e0645\\\">discharge checklist</span> may help reduce the likelihood of readmission for recurrent heart failure.</p>\\n\"",
        "resourceIds": "[\"5cb09c1621c262c35a0e0645\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cb08ca6b9e5980010e9fcd7",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cb08ca6b9e5980010e9fcd6"
      ]
    },
    {
      "id": "5cbf891b305efe0016a09a76",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous diuretics to manage their hypervolemia are at higher risk for recurrent acute heart failure as an outpatient and therefore are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf87ac07881d001522af2a",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is the patient already being treated with a mineralocorticoid receptor antagonist (MRA)?</strong></p>\\n\"",
        "variable": "\"taking_MRA_3\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient being</p>\\n\\n<p>treated with an MRA?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3c58bc24076a92270f78",
        "5caf8b6c07881d001522af37",
        "5cdab6267920bd0015e73249"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdcb",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "true",
        "questionForChildren": "\"<p><strong>Was an echocardiogram performed during this hospitalization?</strong></p>\\n\"",
        "variable": "\"echo_performed_hosp\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Echocardiogram</p>\\n\\n<p>performed during</p>\\n\\n<p>current hospitalization?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "subtreeRoot",
        "node"
      ],
      "children": [
        "5cbf3894bc24076a92270df8",
        "5cad091baa11590010e31628",
        "5cdaa7f27920bd0015e7311f",
        "5ce45694a5a9440015d9da5b"
      ]
    },
    {
      "id": "5cbf8678305efe0016a09a6c",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous diuretics to manage their hypervolemia are at higher risk for recurrent acute heart failure as outpatients and therefore are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270ef8",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Is an ARNI, ACE inhibitor, or ARB not being used for one or both of the following reasons?</strong></p>\\n\\n<ul>\\n   <li>The patient developed an adverse effect from the drug (ie, hypotension, worsening kidney function, or hyperkalemia).</li>\\n   <li>The patient has a history of angioedema or hypersensitivity to ARNIs or ACE inhibitors and has an allergy to single-agent ARBs.</li>\\n</ul>\\n\"",
        "variable": "\"no_ARNI_reason\"",
        "shortTitle": "\"\"",
        "title": "\"<p>ARNI, ACE inhibitor,</p>\\n\\n<p>or ARB not being used due to intolerance?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a00bc24076a92270f03",
        "5cbf3a00bc24076a92270f05",
        "5cdaadd857b1db001544d8c2"
      ]
    },
    {
      "id": "5cdaaa2957b1db001544d8b8",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaaa2857b1db001544d8b7"
      ]
    },
    {
      "id": "5cdaac837920bd0015e7312b",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaac837920bd0015e7312a"
      ]
    },
    {
      "id": "5cbf3a04bc24076a92270f36",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3951bc24076a92270ecb",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3951bc24076a92270eca"
      ]
    },
    {
      "id": "5cbf389bbc24076a92270e63",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf389bbc24076a92270e62"
      ]
    },
    {
      "id": "5cbf8416305efe0016a09a64",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An ARNI, ACE inhibitor, or ARB should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of these drugs in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf39febc24076a92270edf",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf39febc24076a92270ee0"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e05",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3895bc24076a92270e04"
      ]
    },
    {
      "id": "5cbf37ee19dc0b497eb29c2d",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ee19dc0b497eb29c2c"
      ]
    },
    {
      "id": "5cbf875c305efe0016a09a6e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking an ARNI, ACE inhibitor, or ARB for less than 24 hours should be monitored for adverse effects, including hypotension, worsening kidney function, and a concerning rise in serum potassium, before discharge from the hospital is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacfd2fd1653882bffcfd46",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cacfd2fd1653882bffcfd45"
      ]
    },
    {
      "id": "5cb0a17f21c262c35a0e066c",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cdab4c87920bd0015e73242",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>This patient is taking an ARNI, ACE inhibitor, or ARB and is also taking a beta blocker. Have these drugs been continued, without interruption or dose reduction, since prior to hospitalization: $(ARNI_BB_prior_1).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdcf",
      "metadata": {
        "resourceId": "\"5c79305e8050090cc5ac8e50\"",
        "title": "\"Disclaimer\"",
        "content": "\"<p>$(g_disclaimer)</p>\\n\"",
        "resourceType": "\"infoPopup\"",
        "resourceIds": "[]"
      },
      "tags": [
        "infoPopup",
        "resource"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e41",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf389abc24076a92270e52",
        "5cbf8806305efe0016a09a73"
      ]
    },
    {
      "id": "5cdabb66ec199540a8d2e002",
      "metadata": {
        "resourceId": "\"5cdabb66ec199540a8d2e003\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "105338",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"Pharmacologic therapy of heart failure with reduced ejection fraction\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=105338&Bookmark=H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cb0a248f6e0b60013cc31b5",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cb0a248f6e0b60013cc31b4"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29bdd",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37e819dc0b497eb29bdc"
      ]
    },
    {
      "id": "5cbf3899bc24076a92270e4f",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270ef9",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a00bc24076a92270ef8"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e93",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf394dbc24076a92270e92"
      ]
    },
    {
      "id": "5caf91f7c2b59b001152b91d",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf91f7c2b59b001152b91c"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e21",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3897bc24076a92270e20"
      ]
    },
    {
      "id": "5cbf3a00bc24076a92270ef6",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient's blood pressure tolerated the ARNI, ACE inhibitor, or ARB, and have arrangements been made to monitor as an outpatient for worsening kidney function or a concerning rise in serum potassium?</strong></p>\\n\"",
        "variable": "\"BP_stable_ACE\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Stable blood pressure on ARNI, ACE inhibitor,</p>\\n\\n<p>and outpatient laboratory</p>\\n\\n<p>follow-up arranged?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a00bc24076a92270efd",
        "5cbf3a00bc24076a92270eff",
        "5cbf3a00bc24076a92270f01",
        "5cdd9d1b27e26e00102e4f28"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e81",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "true",
        "questionForChildren": "\"<p><strong>Is the patient being treated with one of these medications?</strong></p>\\n\"",
        "variable": "\"taking_RAS_2\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Is the patient being</p>\\n\\n<p>treated with an ARNI,</p>\\n\\n<p>ACE inhibitor, or ARB?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394cbc24076a92270e89",
        "5cbf394cbc24076a92270e8b",
        "5cbf394dbc24076a92270e8d",
        "5cdaacb47920bd0015e7312d"
      ]
    },
    {
      "id": "5caf520bc2b59b001152b6fd",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf520bc2b59b001152b6fc"
      ]
    },
    {
      "id": "5cdd9f8364dab00011f81e84",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient tolerated the beta blocker for at least several hours: $(BB_tolerate_2).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf389bbc24076a92270e62",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate an MRA</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf389bbc24076a92270e68",
        "5cbf8887305efe0016a09a75"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bce",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37e719dc0b497eb29bcd"
      ]
    },
    {
      "id": "5caf8c05c2b59b001152b919",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c05c2b59b001152b918"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdd5",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf94b5c2b59b001152b922",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>The patient is suitable for discharge. Using a <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5cb09c1621c262c35a0e0645\\\">discharge checklist</span> may help reduce the likelihood of readmission for recurrent heart failure.</p>\\n\"",
        "resourceIds": "[\"5cb09c1621c262c35a0e0645\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdab35057b1db001544d92a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Is a beta blocker not being used because the patient has active bronchospasm, because the patient has a hypersensitivity to beta blockers, or because, after it was introduced, it produced hypoperfusion or bradycardia: $(no_BB_reason_1).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaab567920bd0015e73127",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaab567920bd0015e73126"
      ]
    },
    {
      "id": "5cbf3950bc24076a92270ec4",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cb0a2adb9e5980010e9fcd8",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf389abc24076a92270e53",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF who are hospitalized for acute heart failure and who are unable to tolerate treatment with a beta blocker (even at a low dose) should be evaluated by a heart failure specialist before discharge to help navigate treatment options.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3951bc24076a92270ec6",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270ea6",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf394ebc24076a92270ea5"
      ]
    },
    {
      "id": "5cbf394ebc24076a92270ea2",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF who are hospitalized for acute heart failure and who are unable to tolerate treatment with an ARNI, ACE inhibitor, or ARB should be evaluated by a heart failure specialist before discharge to help navigate treatment options.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cf7d6c39a45f75a032fca43",
      "metadata": {
        "autoRouteFormula": "\"$(TTE_ordered) == 1\"",
        "isAutoRouteEnabled": "true",
        "title": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3894bc24076a92270df9"
      ]
    },
    {
      "id": "5caf8c0c07881d001522af3c",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Certain clinical criteria should be satisfied before determining that a patient hospitalized for acute heart failure is suitable for discharge. These include:</p>\\n\\n<ul>\\n   <li>The patient's symptoms (ie, the symptoms of acute heart failure that prompted hospitalization) have improved. As an example, a patient who was too dyspneic to ambulate at the time of hospitalization should be able to ambulate at the time of discharge (unless there is an orthopedic problem interfering with ambulation).</li>\\n   <li>The patient's blood pressure should be controlled, but the patient should not have symptomatic hypotension.</li>\\n   <li>The patient's electrolytes (in particular, potassium, sodium, magnesium) should be normal (or in an acceptable range and either stable or improving) for at least 24 hours.</li>\\n   <li>The patient's kidney function should be stable for at least 24 hours or improving.</li>\\n</ul>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a01bc24076a92270f08",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient tolerated the beta blocker for at least several hours?</strong></p>\\n\"",
        "variable": "\"BB_tolerate\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Has the patient tolerated</p>\\n\\n<p>the beta blocker for</p>\\n\\n<p>at least several hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a02bc24076a92270f16",
        "5cbf3a02bc24076a92270f18",
        "5cbf3a02bc24076a92270f1a",
        "5cdd9f3064dab00011f81e81"
      ]
    },
    {
      "id": "5cdd9d7a27e26e00102e4f29",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient's blood pressure tolerated the ARNI, ACE inhibitor, or ARB, and have arrangements been made to monitor as an outpatient for worsening kidney function or a concerning rise in serum potassium: $(BP_stable_ACE_1).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaaebf7920bd0015e73132",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>ARNIs, ACE inhibitors, and ARBs are often avoided if one or both of the following are present:</p>\\n\\n<ul>\\n   <li>The patient developed an adverse effect from the drug (ie, hypotension, worsening kidney function, or hyperkalemia).</li>\\n   <li>The patient has a history of angioedema or hypersensitivity to ARNIs or ACE inhibitors and has an allergy to single-agent ARBs.</li>\\n</ul>\\n\\n<p>Is an ARNI, ACE inhibitor, or ARB not being used for one or both of these reasons: $(no_ARNI_reason_2).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf3680c2b59b001152b6c6",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cf7d545b8e74100125bf53e",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cf7d545b8e74100125bf53d"
      ]
    },
    {
      "id": "5cdab6257920bd0015e73248",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Is the patient already being treated with an MRA: $(taking_MRA_3).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a03bc24076a92270f2a",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a03bc24076a92270f29"
      ]
    },
    {
      "id": "5cbf3a04bc24076a92270f3a",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5caf521207881d001522ac9a",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cad0911a23d7e0015f1ad3e",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf82f5305efe0016a09a60",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking a beta blocker for less than 24 hours should be monitored for adverse effects, including hypoperfusion and bradycardia, before discharge from the hospital is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a02bc24076a92270f1d",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate (or resume)</p>\\n\\n<p>therapy with a</p>\\n\\n<p>beta blocker</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a03bc24076a92270f2d",
        "5cbf8a35305efe0016a09a7b"
      ]
    },
    {
      "id": "5cbf88e62acfa8001101e405",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf88e62acfa8001101e404"
      ]
    },
    {
      "id": "5cbf3896bc24076a92270e1b",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf8c0c07881d001522af3a"
      ]
    },
    {
      "id": "5cdab0957920bd0015e73134",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with a beta blocker to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should generally be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\\n<p>Is the patient being treated with a beta blocker: $(taking_BB_3).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cc04b714f86a845f9694ff3",
      "metadata": {
        "resourceId": "\"5cc04b714f86a845f9694ff4\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "7021",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"pneumococcus\"",
        "url": "\"https://qawww.utdlab.com/contents/7021?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cb089527002070be1d00189",
      "metadata": {
        "resourceId": "\"5cb089527002070be1d0018a\"",
        "headingReferenceId": "\"H54671266\"",
        "contentId": "3861",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"goal blood pressure\"",
        "url": "\"https://qawww.utdlab.com/contents/3861?source=icg&topicId=120904&anchor=H54671266#H54671266\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdc5",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient's precipitating disorder (or disorders) been suitably treated?</strong></p>\\n\"",
        "variable": "\"suitable_rx\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Has the precipitating</p>\\n\\n<p>factor (or factors) been</p>\\n\\n<p>suitably treated?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cacf86f21c1f40010d2fdc6",
        "5cdd9a0e64dab00011f81e7b",
        "5cb0a09621c262c35a0e0651",
        "5cb08ca6b9e5980010e9fcd5"
      ]
    },
    {
      "id": "5cbf37eb19dc0b497eb29c07",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An ARNI, ACE inhibitor, or ARB should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of these drugs in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdcc",
      "metadata": {
        "resourceId": "\"5c7930208050090cc5ac8e4c\"",
        "title": "\"Exclusions\"",
        "content": "\"<p>This UpToDate Pathway&nbsp;<strong>is not</strong>&nbsp;appropriate for patients with any of the following exclusions:</p>\\n\\n<ul>\\n   <li>Age &lt;18 years</li>\\n   <li>Pregnant</li>\\n   <li>Patient with a mechanical circulatory assist device</li>\\n   <li>Patient with a cardiac transplant</li>\\n   <li>Patient receiving continuous or intermittent renal replacement therapy</li>\\n</ul>\\n\"",
        "resourceIds": "[]",
        "resourceType": "\"infoPopup\""
      },
      "tags": [
        "infoPopup",
        "resource"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270ea8",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394fbc24076a92270ea7"
      ]
    },
    {
      "id": "5caf520bc2b59b001152b6fe",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>In patients with HFrEF, beta blockers may cause hypoperfusion and bradycardia. If a beta blocker is newly initiated or resumed after discontinuation, the patient should be monitored for at least several hours for these potential complications.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf7a11305efe0016a09a59",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf7a10305efe0016a09a58"
      ]
    },
    {
      "id": "5caf849a07881d001522ae09",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf849a07881d001522ae08"
      ]
    },
    {
      "id": "5cbf3a03bc24076a92270f30",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Based upon the above criteria, should the patient be initiated on an MRA?</strong></p>\\n\"",
        "variable": "\"MRA_indicated\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Should an MRA</p>\\n\\n<p>be initiated?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3a04bc24076a92270f39",
        "5cbf3a04bc24076a92270f3a",
        "5cbf3a04bc24076a92270f3c",
        "5cdab6aa7920bd0015e7324b"
      ]
    },
    {
      "id": "5cdd9f5f64dab00011f81e82",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient tolerated the beta blocker for at least several hours: $(BB_tolerate_1).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdab5d857b1db001544d9ba",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Is the patient already being treated with an MRA: $(taking_MRA_1).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cf7ed96c94a2d2877b1d841",
      "metadata": {
        "autoRouteFormula": "\"$(EP_consult_ordered) == 1\"",
        "isAutoRouteEnabled": "true",
        "title": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3895bc24076a92270e04"
      ]
    },
    {
      "id": "5cad0baeaa11590010e3162e",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cad0baeaa11590010e3162d"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e7c",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf394cbc24076a92270e7b"
      ]
    },
    {
      "id": "5caf363107881d001522ac6a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>The patient has one or more reasons to be evaluated by an electrophysiologist. An EP consultation should be ordered, although this is typically done as an outpatient (arranged prior to discharge).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf31d84ac0c658ab9bf260",
      "metadata": {
        "resourceId": "\"5caf31d84ac0c658ab9bf261\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "91077",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"primary prevention\"",
        "url": "\"https://qawww.utdlab.com/contents/91077?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf7b0b305efe0016a09a5a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>The patient is <strong>not</strong> ready for discharge. Precipitating factors should be adequately treated. Readmission for recurrent acute heart failure is likely if these conditions are not suitably managed.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf39ffbc24076a92270ef0",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf39ffbc24076a92270eef"
      ]
    },
    {
      "id": "5caf9590fb724bd988d11891",
      "metadata": {
        "resourceId": "\"5caf9590fb724bd988d11892\"",
        "displayTag": "\"2\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "120488",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Pathways\"",
        "url": "\"https://qawww.utdlab.com/pathway/120488?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-Pathway\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf87bb305efe0016a09a70",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>A beta blocker should be initiated (if the patient was not taking one prior to hospitalization) or resumed (if the drug was discontinued during hospitalization, even if it is resumed at a dose that is lower than the prior outpatient dose).</p>\\n\\n<p>Guidance on initiation and titration of beta blockers in patients with HFrEF can be found in UpToDate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4acdec403d1d8127a2ec\\\">topics</span> and in a separate <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5caf4aebec403d1d8127a2ee\\\">Pathway</span>.</p>\\n\\n<p>After initiating or resuming the drug, the patient should be monitored for at least 24 hours (for potential adverse effects) before discharge is considered.</p>\\n\"",
        "resourceIds": "[\"5caf4acdec403d1d8127a2ec\",\"5caf4aebec403d1d8127a2ee\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3898bc24076a92270e33",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3898bc24076a92270e32"
      ]
    },
    {
      "id": "5caf4894c2b59b001152b6f0",
      "metadata": {
        "nodes": "[{\"id\":\"5caf4894c2b59b001152b6f1\",\"type\":\"start\",\"position\":{\"x\":80,\"y\":0}},{\"id\":\"5caf4894c2b59b001152b6f2\",\"type\":\"endpoint\",\"position\":{\"x\":80,\"y\":260}},{\"id\":\"5caf489c0ed6cd4c49255cd1\",\"title\":\"Heart failure consult\",\"description\":\"<p><strong>Consult a heart failure specialist.</strong></p>\\n\",\"type\":\"radio\",\"variable\":\"order_HFconsult_1\",\"options\":[{\"selectedValue\":\"Obtain a heart failure specialist consult\",\"variable\":\"order_HFconsult_1_opt1\",\"title\":\"<p>Obtain&nbsp;a heart failure specialist consult</p>\\n\",\"includeInSummary\":true,\"orderSummary\":\"<p>$(order_HFconsult_1)</p>\\n\",\"decisionSummary\":\"<p>Approach selected: $(order_HFconsult_1).</p>\\n\",\"category\":\"others\"},{\"selectedValue\":\"Approach other than consulting a heart failure specialist\",\"variable\":\"order_HFconsult_1_opt2\",\"title\":\"<p>Approach other than consulting a heart failure specialist</p>\\n\",\"includeInSummary\":true,\"orderSummary\":\"<p>$(order_HFconsult_1)</p>\\n\",\"decisionSummary\":\"<p>Approach selected: $(order_HFconsult_1).</p>\\n\",\"category\":\"others\"}],\"position\":{\"x\":80,\"y\":130},\"blockRender\":false,\"category\":\"others\",\"orderSummary\":\"<p>$(order_HFconsult_1)</p>\\n\",\"decisionSummary\":\"<p>Approach selected: $(order_HFconsult_1).</p>\\n\",\"includeInSummary\":true}]",
        "title": "\"<p>Heart failure consult</p>\\n\"",
        "connections": "[{\"source\":\"5caf4894c2b59b001152b6f1:out:0\",\"target\":\"5caf489c0ed6cd4c49255cd1:in\",\"id\":\"5ce8658b85004208145fd3ea\"},{\"source\":\"5caf489c0ed6cd4c49255cd1:out:0\",\"target\":\"5caf4894c2b59b001152b6f2:in\",\"id\":\"5ce8658b85004208145fd3eb\"}]",
        "resourceIds": "[]",
        "embedProperties": "{\"isExtraCommentSelected\":false}"
      },
      "tags": [
        "orderSet"
      ]
    },
    {
      "id": "5cbf394cbc24076a92270e87",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf394cbc24076a92270e86"
      ]
    },
    {
      "id": "5cbf37e619dc0b497eb29bc7",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient been evaluated by an electorphysiology (EP) specialist?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5ce822d038e9311ed81f1c59",
      "metadata": {
        "resourceId": "\"5ce822d038e9311ed81f1c5a\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3446",
        "isOriginalDescription": "true",
        "active": "true",
        "text": "\"Patient education: Heart failure (Beyond the Basics)\"",
        "url": "\"https://qawww.utdlab.com/contents/3446?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-PAT\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5caf8b4e07881d001522af34",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdd9d1b27e26e00102e4f27",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient's blood pressure tolerated the ARNI, ACE inhibitor, or ARB, and have arrangements been made to monitor as an outpatient for worsening kidney function or a concerning rise in serum potassium: $(BP_stable_ACE).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e96",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Initiate (or resume)</p>\\n\\n<p>therapy with an ARNI,</p>\\n\\n<p>ACE inhibitor, or ARB</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394fbc24076a92270ea6",
        "5cbf8416305efe0016a09a65"
      ]
    },
    {
      "id": "5cbf81f62acfa8001101e3f8",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have been taking an ARNI, ACE inhibitor, or ARB for less than 24 hours should be monitored for adverse effects, including hypotension, worsening kidney function, and a concerning rise in serum potassium, before discharge from the hospital is considered.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdc8",
      "metadata": {
        "isSummaryLink": "false",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cacf86f21c1f40010d2fdc9"
      ]
    },
    {
      "id": "5cb08b287002070be1d0018f",
      "metadata": {
        "resourceId": "\"5cb08b287002070be1d00190\"",
        "displayTag": "\"2\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "120056",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Pathway\"",
        "url": "\"https://qawww.utdlab.com/pathway/120056?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-Pathway\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cdaa8e87920bd0015e73121",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaa8e87920bd0015e73120"
      ]
    },
    {
      "id": "5cbf8887305efe0016a09a75",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf8887305efe0016a09a74"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29bdf",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37e819dc0b497eb29bde"
      ]
    },
    {
      "id": "5cacfb3baa11590010e31625",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Serial serum creatinine values (to determine the trend in kidney function) and serial serum electrolytes (ie, sodium, potassium) are required to answer the questions that will follow.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf3df4c2b59b001152b6cc",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient been treated with oral diuretics (without any intravenous diuretic therapy) for at least 24 hours, and is the volume status stable or improving?</strong></p>\\n\"",
        "variable": "\"volume_stable_better_24_3\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Stable or improving</p>\\n\\n<p>volume status while</p>\\n\\n<p>taking oral diuretics for</p>\\n\\n<p>at least 24 hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf3fa2c2b59b001152b6d1",
        "5caf3fa7c2b59b001152b6d5",
        "5cdaaacc57b1db001544d8bc"
      ]
    },
    {
      "id": "5caf4f3d07881d001522ac8d",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf4f3d07881d001522ac8c"
      ]
    },
    {
      "id": "5caf8c0c07881d001522af3a",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "true",
        "questionForChildren": "\"<p><strong>Are the above clinical criteria for discharge satisfied?</strong></p>\\n\"",
        "variable": "\"clin_crit\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Clinical criteria for discharge satisfied?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "subtreeRoot",
        "node"
      ],
      "children": [
        "5caf8c0c07881d001522af3d",
        "5caf91f007881d001522af3f",
        "5caf91f7c2b59b001152b91d",
        "5cdab7c057b1db001544d9bf"
      ]
    },
    {
      "id": "5cbf82f5305efe0016a09a61",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf82f5305efe0016a09a60"
      ]
    },
    {
      "id": "5cdaa93357b1db001544d8b3",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Consultation with an EP specialist to consider indications for an <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d02507acaa878f8603cb5a1\\\">ICD</span> or for <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d025097caa878f8603cb5a3\\\">CRT</span> is suggested for:</p>\\n\\n<ul>\\n   <li>Patients with HFrEF, an ejection fraction &le;35%, and <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2cda47d2eeaad4d3417478\\\">NYHA functional class</span> II or III.</li>\\n   <li>Patients with HFrEF, a history of ischemic heart disease, an ejection fraction &le;35%, and NYHA class I, II, or III.</li>\\n   <li>Patients with HFrEF, an ejection fraction &le;35%, a QRS duration &ge;120 milliseconds, and NYHA class IV.</li>\\n   <li>Patients who have survived an episode of SCD (prior to or during this hospitalization).</li>\\n   <li>Patients with a history of sustained VT.</li>\\n   <li>Patients with an ischemic heart disease and unexplained syncope.</li>\\n   <li>Patients with NYHA class III or IV who have a QRS duration &ge;150 milliseconds and LBBB.</li>\\n   <li>Patients with atrial fibrillation in whom rhythm and/or rate control has proven difficult to attain.</li>\\n</ul>\\n\\n<p>Does the patient have any of the above reasons to undergo evaluation by an electrophysiologist: $(EP_indication).</p>\\n\"",
        "resourceIds": "[\"5d02507acaa878f8603cb5a1\",\"5d025097caa878f8603cb5a3\",\"5d2cda47d2eeaad4d3417478\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacfd30d1653882bffcfd4c",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cacfd30d1653882bffcfd4b"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdcd",
      "metadata": {
        "isSummaryLink": "false",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cacf86f21c1f40010d2fdd4"
      ]
    },
    {
      "id": "5ce69143c8bc68582218ebfd",
      "metadata": {
        "resourceId": "\"5ce69143c8bc68582218ebfe\"",
        "displayTag": "\"2\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "120056",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"UpToDate Pathway\"",
        "url": "\"https://qawww.utdlab.com/pathway/120056?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-Pathway\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bfb",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Has the patient tolerated the beta blocker for at least 24 hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c0a",
        "5cbf37ec19dc0b497eb29c0c",
        "5cbf37ec19dc0b497eb29c0e"
      ]
    },
    {
      "id": "5cdab3a357b1db001544d944",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab3a357b1db001544d943"
      ]
    },
    {
      "id": "5ce838afe0b85d7d8f548e6d",
      "metadata": {
        "resourceId": "\"5ce838afe0b85d7d8f548e6e\"",
        "headingReferenceId": "\"H17676495\"",
        "contentId": "105338",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"topics\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=105338&Bookmark=H17676495\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c18",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c17"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29be3",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37e819dc0b497eb29be2"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e2c",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Consult a heart</p>\\n\\n<p>failure specialist</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3898bc24076a92270e3b",
        "5cbf3898bc24076a92270e3c"
      ]
    },
    {
      "id": "5caf41d7c2b59b001152b6df",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf41d7c2b59b001152b6de"
      ]
    },
    {
      "id": "5cdab7c057b1db001544d9bf",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab7c057b1db001544d9be"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdc1",
      "metadata": {
        "layout": "{\"width\":180,\"height\":60,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "questionForChildren": "\"\"",
        "isChildrenHidden": "false",
        "shortTitle": "\"\"",
        "isDefaultTitle": "false",
        "title": "\"<p>asd</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cacf86f21c1f40010d2fdcd",
        "5cacf86f21c1f40010d2fdce",
        "5cacf86f21c1f40010d2fdc8"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e98",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>&nbsp;</p>\\n\\n<ul>\\n</ul>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacfd2fd1653882bffcfd45",
      "metadata": {
        "layout": "{\"width\":140,\"height\":60,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "title": "\"Fill in Node Title\""
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cacfd30d1653882bffcfd4c"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e29",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3897bc24076a92270e28"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29bde",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37e919dc0b497eb29be8"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bf4",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37ea19dc0b497eb29bf3"
      ]
    },
    {
      "id": "5ce6a7a3b5c7c8a0fa3bdfb4",
      "metadata": {
        "resourceId": "\"5ce6a7a3b5c7c8a0fa3bdfb5\"",
        "contentId": "52683",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"New York Heart Association (NYHA) functional class\"",
        "url": "\"https://qawww.utdlab.com/contents/image?imageKey=ID/52683&source=icg&topicId=120904\"",
        "resourceType": "\"utd-Graphic\""
      },
      "tags": [
        "resource",
        "utd-Graphic"
      ]
    },
    {
      "id": "5ced48ebf5bc96001112f30b",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient received intravenous inotropes or vasodilators during the previous 24 hours: $(inotropes_yes_3).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdaa7f27920bd0015e7311f",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdaa7f27920bd0015e7311e"
      ]
    },
    {
      "id": "5cbf37e819dc0b497eb29bdb",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37e819dc0b497eb29bda"
      ]
    },
    {
      "id": "5caf363107881d001522ac69",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf363107881d001522ac68"
      ]
    },
    {
      "id": "5d2e2bbfc95553ffb5bdad7b",
      "metadata": {
        "resourceId": "\"5d2e2bbfc95553ffb5bdad7c\"",
        "headingReferenceId": "\"H15\"",
        "contentId": "3464",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"UpToDate content\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=3464&Bookmark=H15\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cbf37ea19dc0b497eb29bee",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37e919dc0b497eb29bed"
      ]
    },
    {
      "id": "5cdab14c57b1db001544d8c7",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with a beta blocker to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should generally be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\\n<p>Is the patient being treated with a beta blocker: $(taking_BB_1).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cad0c09a23d7e0015f1ad40",
      "metadata": {
        "nodes": "[{\"id\":\"5cad0c09a23d7e0015f1ad41\",\"type\":\"start\",\"position\":{\"x\":80,\"y\":0}},{\"id\":\"5cad0c09a23d7e0015f1ad42\",\"type\":\"endpoint\",\"position\":{\"x\":80,\"y\":390},\"decisionSummaryCompleted\":\"\",\"summarySkipped\":\"<p>Select &quot;Reset&quot;&nbsp;to indicate whether a transthoracic ultrasound will be ordered.</p>\\n\",\"decisionSummarySkipped\":\"<p>Approach selected: No orders were selected.</p>\\n\",\"useSkippedSummaryAsDecisionSummary\":false},{\"id\":\"5cad0c1f34bc2dbc936fe35b\",\"title\":\"TTE\",\"description\":\"<p><strong>Order a transthoracic echocardiogram.</strong></p>\\n\",\"type\":\"radio\",\"variable\":\"order_TTE_1\",\"options\":[{\"selectedValue\":\"Transthoracic echocardiogram\",\"variable\":\"order_TTE_1_opt1\",\"title\":\"<p>Transthoracic echocardiogram</p>\\n\",\"includeInSummary\":true,\"orderSummary\":\"<p>$(order_TTE_1)</p>\\n\",\"decisionSummary\":\"<p>Approach selected: $(order_TTE_1).</p>\\n\",\"category\":\"tests\"},{\"selectedValue\":\"Approach other than ordering a transthoracic echocardiogram\",\"variable\":\"order_TTE_1_opt2\",\"title\":\"<p>Approach other than ordering a transthoracic echocardiogram</p>\\n\",\"includeInSummary\":true,\"orderSummary\":\"<p>$(order_TTE_1)</p>\\n\",\"decisionSummary\":\"<p>Approach selected: $(order_TTE_1).</p>\\n\",\"category\":\"tests\"}],\"position\":{\"x\":80,\"y\":130},\"blockRender\":false,\"category\":\"tests\",\"orderSummary\":\"<p>$(order_TTE_1)</p>\\n\",\"decisionSummary\":\"<p>Approach selected: $(order_TTE_1).</p>\\n\",\"includeInSummary\":true},{\"id\":\"5cf7d4ee2409ca7db27972ee\",\"type\":\"function\",\"expression\":\"$(TTE_ordered) = 1\",\"position\":{\"x\":80,\"y\":260}}]",
        "title": "\"<p>Order a transthoracic echocardiogram</p>\\n\"",
        "connections": "[{\"source\":\"5cad0c09a23d7e0015f1ad41:out:0\",\"target\":\"5cad0c1f34bc2dbc936fe35b:in\",\"id\":\"5d2e1514720295b80c30d792\"},{\"source\":\"5cad0c1f34bc2dbc936fe35b:out:0\",\"target\":\"5cf7d4ee2409ca7db27972ee:in\",\"id\":\"5d2e1514720295b80c30d793\"},{\"source\":\"5cf7d4ee2409ca7db27972ee:out:0\",\"target\":\"5cad0c09a23d7e0015f1ad42:in\",\"id\":\"5d2e1514720295b80c30d794\"}]",
        "embedProperties": "{\"isExtraCommentSelected\":false}",
        "resourceIds": "[]"
      },
      "tags": [
        "orderSet"
      ]
    },
    {
      "id": "5caf3fa2c2b59b001152b6d0",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Does the patient have HFrEF?</strong></p>\\n\"",
        "variable": "\"HFrEF_present_3\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Does the patient</p>\\n\\n<p>have HFrEF?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf41d7c2b59b001152b6dd",
        "5cb0a17f21c262c35a0e066c",
        "5cdaabb87920bd0015e73129"
      ]
    },
    {
      "id": "5caf8416c2b59b001152b843",
      "metadata": {
        "layout": "{\"width\":180,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>This patient is taking an ARNI, ACE inhibitor, or ARB and is also taking a beta blocker. Have these drugs been continued, without interruption or dose reduction, since prior to hospitalization?</strong></p>\\n\"",
        "variable": "\"ARNI_BB_prior_3\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Beta blocker and ARNI,</p>\\n\\n<p>ACE inhibitor, or ARB continued</p>\\n\\n<p>at same doses since before</p>\\n\\n<p>hospitalization?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf87ac07881d001522af2b",
        "5cbf3c44bc24076a92270f73",
        "5cdab52957b1db001544d9b9"
      ]
    },
    {
      "id": "5cbf891b305efe0016a09a77",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf891b305efe0016a09a76"
      ]
    },
    {
      "id": "5caf4b5f07881d001522ac82",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Was the patient taking the ARNI, ACE inhibitor, or ARB prior to hospitalization <strong>and</strong> was the drug continued (without dose reduction) during hospitalizaton?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdab6aa7920bd0015e7324b",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab6aa7920bd0015e7324a"
      ]
    },
    {
      "id": "5cbf3896bc24076a92270e17",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3895bc24076a92270e01",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3894bc24076a92270e00"
      ]
    },
    {
      "id": "5cbf7f402acfa8001101e3f6",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous inotropes or intravenous vasodilators to manage their heart failure are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf31b54ac0c658ab9bf25e",
      "metadata": {
        "resourceId": "\"5caf31b54ac0c658ab9bf25f\"",
        "contentId": "52683",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"New York Heart Association (NYHA) functional class\"",
        "url": "\"https://qawww.utdlab.com/contents/image?imageKey=ID/52683&source=icg&topicId=120904\"",
        "resourceType": "\"utd-Graphic\""
      },
      "tags": [
        "resource",
        "utd-Graphic"
      ]
    },
    {
      "id": "5cdab17657b1db001544d8c9",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with a beta blocker to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should generally be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\\n<p>Is the patient being treated with a beta blocker: $(taking_BB_2).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdab72757b1db001544d9bd",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab72657b1db001544d9bc"
      ]
    },
    {
      "id": "5cf7d4ceb8e74100125bf53a",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cf7d4ceb8e74100125bf539"
      ]
    },
    {
      "id": "5cbf394fbc24076a92270eab",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>In patients with HFrEF, beta blockers may cause hypoperfusion and bradycardia. If a beta blocker is newly initiated or resumed after discontinuation, the patient should be monitored for at least several hours for these potential complications.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf520bc2b59b001152b6ff",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5caf520bc2b59b001152b6fe"
      ]
    },
    {
      "id": "5cdaaee157b1db001544d8c3",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>ARNIs, ACE inhibitors, and ARBs are often avoided if one or both of the following are present:</p>\\n\\n<ul>\\n   <li>The patient developed an adverse effect from the drug (ie, hypotension, worsening kidney function, or hyperkalemia).</li>\\n   <li>The patient has a history of angioedema or hypersensitivity to ARNIs or ACE inhibitors and has an allergy to single-agent ARBs.</li>\\n</ul>\\n\\n<p>Is an ARNI, ACE inhibitor, or ARB not being used for one or both of these reasons: $(no_ARNI_reason_3).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdabb51ec199540a8d2e000",
      "metadata": {
        "resourceId": "\"5cdabb51ec199540a8d2e001\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3508",
        "isOriginalDescription": "false",
        "active": "false",
        "text": "\"Overview of the therapy of heart failure with reduced ejection fraction\"",
        "url": "\"http://editorial00p/Topic/OpenTopic.aspx?view=web&TopicID=3508&Bookmark=H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cb08c9eb9e5980010e9fcd2",
      "metadata": {
        "title": "null"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf37e919dc0b497eb29be7",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Do not discharge the patient. Patients who have required intravenous diuretics to manage their hypervolemia are at higher risk for recurrent acute heart failure as an outpatient and therefore are not appropriate for hospital discharge.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf394dbc24076a92270e9a",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient tolerated the beta blocker for at least several hours?</strong></p>\\n\"",
        "variable": "\"BB_tolerate_2\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Has the patient tolerated</p>\\n\\n<p>the beta blocker for</p>\\n\\n<p>at least several hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf394fbc24076a92270ea8",
        "5cbf394fbc24076a92270eaa",
        "5cbf394fbc24076a92270eac",
        "5cdd9f8364dab00011f81e85"
      ]
    },
    {
      "id": "5ced48cbf5bc96001112f30a",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5ced48cbf5bc96001112f309"
      ]
    },
    {
      "id": "5caf8b6c07881d001522af36",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Based upon the above criteria, should the patient be initiated on an MRA?</strong></p>\\n\"",
        "variable": "\"MRA_indicated_3\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Should an MRA</p>\\n\\n<p>be initiated?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf8b6c07881d001522af39",
        "5caf8c05c2b59b001152b919",
        "5caf8c0c07881d001522af3b",
        "5cdab7577920bd0015e7324f"
      ]
    },
    {
      "id": "5cbf85b1305efe0016a09a6a",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>An MRA should be initiated. Guidance on initiation and titration of these agents in patients with HFrEF can be found in related <span class=\\\"tf-content-reference tf-content-reference-link-active\\\" contenteditable=\\\"false\\\" tf-resource-id=\\\"5d2e2b8fc95553ffb5bdad74\\\">UpToDate content</span>.</p>\\n\\n<p>After initiating an MRA, a discharged patient should be monitored carefully for the development of worsening kidney function or hyperkalemia.</p>\\n\"",
        "resourceIds": "[\"5d2e2b8fc95553ffb5bdad74\"]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cdab52957b1db001544d9b9",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab52957b1db001544d9b8"
      ]
    },
    {
      "id": "5cbf37e719dc0b497eb29bd8",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient received intravenous inotropes or vasodilators during the previous 24 hours?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a04bc24076a92270f3c",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf3a04bc24076a92270f3b"
      ]
    },
    {
      "id": "5cbf37ed19dc0b497eb29c1d",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF who are hospitalized for acute heart failure and who are unable to tolerate treatment with a beta blocker (even at a low dose) should be evaluated by a heart failure specialist to help navigate other treatment options.\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a03bc24076a92270f32",
      "metadata": {
        "title": "\"\"",
        "content": "\"\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3a01bc24076a92270f0b",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf3a01bc24076a92270f0a"
      ]
    },
    {
      "id": "5caf4f3d07881d001522ac8e",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Patients with HFrEF should be treated with a beta blocker to reduce morbidity and mortality.</p>\\n\\n<p>In such patients who are admitted for acute heart failure, these drugs should generally be initiated (if the patient was not previously treated), resumed (if the drug was stopped during hospitalization), or continued.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cbf3897bc24076a92270e20",
      "metadata": {
        "layout": "{\"width\":160,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Has the patient's blood pressure tolerated the ARNI, ACE inhibitor, or ARB, and have arrangements been made to monitor as an outpatient for worsening kidney function or a concerning rise in serum potassium?</strong></p>\\n\"",
        "variable": "\"BP_stable_ACE_2\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Stable blood pressure on ARNI, ACE inhibitor,</p>\\n\\n<p>and outpatient laboratory</p>\\n\\n<p>follow-up arranged?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf3897bc24076a92270e27",
        "5cbf3897bc24076a92270e29",
        "5cbf3897bc24076a92270e2b",
        "5cdd9da164dab00011f81e7d"
      ]
    },
    {
      "id": "5cbf8523305efe0016a09a69",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf8523305efe0016a09a68"
      ]
    },
    {
      "id": "5cbf39ffbc24076a92270ee9",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":0}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"<p><strong>Does the patient have heart failure with reduced ejection fraction (HFrEF)?</strong></p>\\n\"",
        "variable": "\"HFrEF_present\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Does the patient</p>\\n\\n<p>have HFrEF?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf39ffbc24076a92270ef0",
        "5cbf39ffbc24076a92270ef1",
        "5cdaab267920bd0015e73125"
      ]
    },
    {
      "id": "5cbf8994305efe0016a09a79",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf8994305efe0016a09a78"
      ]
    },
    {
      "id": "5cdabb30ec199540a8d2dffc",
      "metadata": {
        "resourceId": "\"5cdabb30ec199540a8d2dffd\"",
        "headingReferenceId": "\"H00\"",
        "contentId": "3475",
        "isOriginalDescription": "false",
        "active": "true",
        "text": "\"Cardiac resynchronization therapy in heart failure: Indications\"",
        "url": "\"https://qawww.utdlab.com/contents/3475?source=icg&topicId=120904&anchor=H00#H00\"",
        "resourceType": "\"utd-MED\""
      },
      "tags": [
        "resource",
        "utd-MED"
      ]
    },
    {
      "id": "5cdab5a27920bd0015e73245",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdab5a17920bd0015e73244"
      ]
    },
    {
      "id": "5ced4853f5bc96001112f305",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>Has the patient received intravenous inotropes or vasodilators during the previous 24 hours: $(inotropes_yes).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5caf4b6607881d001522ac84",
      "metadata": {
        "layout": "{\"width\":140,\"height\":80,\"offsetNodeByY\":0,\"offsetNodeByX\":1}",
        "isCustomSummary": "true",
        "isCollapsed": "false",
        "questionForChildren": "\"\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Do not discharge</p>\\n\\n<p>the patient</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5caf4b6607881d001522ac87",
        "5cbf81f62acfa8001101e3f9"
      ]
    },
    {
      "id": "5cbf37e619dc0b497eb29bc5",
      "metadata": {
        "isCustomSummary": "false",
        "isCollapsed": "false",
        "questionForChildren": "\"Choose an option:\"",
        "shortTitle": "\"\"",
        "title": "\"<p>Reason to obtain an electrophysiology (EP) consult?</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "node"
      ],
      "children": [
        "5cbf37e719dc0b497eb29bcc",
        "5cbf37e719dc0b497eb29bce",
        "5cbf37e719dc0b497eb29bd0"
      ]
    },
    {
      "id": "5cbf37ec19dc0b497eb29c16",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cbf37ec19dc0b497eb29c15"
      ]
    },
    {
      "id": "5cdaae897920bd0015e73130",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>ARNIs, ACE inhibitors, and ARBs are often avoided if one or both of the following are present:</p>\\n\\n<ul>\\n   <li>The patient developed an adverse effect from the drug (ie, hypotension, worsening kidney function, or hyperkalemia).</li>\\n   <li>The patient has a history of angioedema or hypersensitivity to ARNIs or ACE inhibitors and has an allergy to single-agent ARBs.</li>\\n</ul>\\n\\n<p>Is an ARNI, ACE inhibitor, or ARB not being used for one or both of these reasons: $(no_ARNI_reason_1).</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cb08ca6b9e5980010e9fcd6",
      "metadata": {
        "title": "\"\"",
        "content": "\"<p>The patient is <strong>not</strong> ready for discharge. Precipitating factors should be adequately treated. Readmission for recurrent acute heart failure is likely if these conditions are not suitably managed.</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "content"
      ]
    },
    {
      "id": "5cacf86f21c1f40010d2fdc4",
      "metadata": {
        "title": "\"<p>Yes</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5cacf86f21c1f40010d2fdc5"
      ]
    },
    {
      "id": "5caf3fa7c2b59b001152b6d5",
      "metadata": {
        "title": "\"<p>No</p>\\n\"",
        "resourceIds": "[]"
      },
      "tags": [
        "link"
      ],
      "children": [
        "5caf3fa7c2b59b001152b6d4"
      ]
    },
    {
      "id": "5cbf37e619dc0b497eb29bc8",
      "metadata": {
        "title": "\"\""
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cbf37e619dc0b497eb29bc7"
      ]
    },
    {
      "id": "5cdd9f3064dab00011f81e81",
      "metadata": {
        "isSummaryLink": "true",
        "title": "null"
      },
      "tags": [
        "extensionLink"
      ],
      "children": [
        "5cdd9f3064dab00011f81e80"
      ]
    }
  ]
}